authorkeywords,total publications,2011,2012,2013,2014,2015,2016,2017,2018,2019,2020,2021,2022,2023
ALI/ARDS,520,11,21,25,31,38,27,40,48,41,53,61,73,51
ECs/HPMECs/HUVECs/MPVECs,288,6,11,17,15,18,22,17,21,25,29,38,44,25
Inflammation,118,5,5,8,2,4,3,10,12,13,13,14,15,14
permeability,99,4,2,9,5,10,5,5,9,13,11,14,11,1
LPS,85,3,2,2,7,13,4,4,11,7,6,12,12,2
sepsis,83,1,5,4,2,1,4,6,6,8,13,8,14,11
apoptosis,62,3,0,3,2,3,7,3,9,1,10,10,8,3
COVID-19/SARS-CoV-2/Coronavirus,33,0,0,0,0,0,0,0,1,0,4,14,8,6
NF-kappa B,31,0,0,2,3,2,0,2,4,3,2,3,6,4
MAPK,24,1,4,1,1,3,3,1,1,1,2,3,3,0
ventilator-induced lung injury,23,0,0,2,5,4,0,1,2,1,1,3,3,1
ROS,23,1,2,3,0,1,1,3,3,1,1,3,4,0
VE-cadherin,20,0,0,2,0,4,3,1,0,1,3,2,3,1
mesenchymal stem cell,19,0,0,0,1,1,3,2,2,3,2,2,2,1
endothelial dysfunction,18,0,0,2,0,1,0,2,0,3,2,3,3,2
tight junction,18,0,0,3,1,0,1,0,3,2,2,2,1,3
oxidative stress,17,0,1,0,0,0,0,2,2,1,0,0,5,6
angiopoietin-1/angiopoietin-2,16,0,0,3,1,0,4,2,2,1,1,0,1,1
transfusion,16,2,3,3,0,1,0,0,1,1,0,0,5,0
S1P/S1PR1/S1PR2/S1PR3,16,1,2,1,1,0,3,1,1,0,2,1,3,0
lung,16,0,1,2,0,1,3,2,0,2,2,1,2,0
cytoskeleton,15,1,0,1,1,5,0,1,0,0,1,3,1,1
Rho/RhoA,15,0,0,0,1,1,1,4,3,0,2,3,0,0
cytokines,14,1,1,1,2,0,1,0,1,2,0,3,1,1
TLR/TLR2/TLR4,14,0,1,1,1,0,1,0,1,0,1,3,4,1
ACE/ACE2,14,0,0,0,0,3,1,1,1,0,1,3,3,1
neutrophils,14,1,3,3,0,0,1,0,0,1,1,0,4,0
autophagy,13,0,0,0,0,1,0,1,3,1,0,2,2,3
endothelial glycocalyx (EG),13,0,0,0,0,0,2,0,3,1,2,2,0,3
pyroptosis,13,0,0,0,0,0,0,0,0,1,0,1,9,2
ICAM-1,13,1,0,1,2,0,2,2,2,0,1,2,0,0
TNF/TNF-alpha/TNFR1,12,2,0,1,2,2,1,1,0,0,0,1,0,2
ischemia/reperfusion,12,0,3,0,0,1,1,1,1,1,3,1,0,0
adhesion junction,12,1,0,1,1,2,1,0,3,0,1,2,0,0
miRNA,11,0,0,1,1,0,0,1,1,2,2,2,1,0
coagulation,10,0,0,0,0,0,1,2,0,1,2,0,3,1
pulmonary edema,10,0,1,1,2,2,0,2,0,0,0,1,1,0
neutrophil,9,0,3,0,1,0,3,0,0,0,0,0,0,2
angiogenesis,9,1,0,1,0,0,0,0,2,1,1,1,1,1
VEGF/VEGFA,9,1,0,0,1,2,1,1,0,0,1,1,0,1
endothelial progenitor cells,9,0,0,2,1,2,0,0,1,2,0,0,0,1
pneumonia,9,0,0,2,0,1,0,2,1,0,1,0,1,1
hyperoxia,9,0,0,2,1,0,1,0,0,2,0,1,2,0
HMGB1,9,1,0,0,1,0,1,0,2,0,1,2,1,0
NO,9,0,3,1,1,1,0,1,0,0,0,1,1,0
eNOS,9,0,0,2,1,0,0,1,0,1,0,4,0,0
pulmonary,8,0,0,2,0,1,1,0,0,0,1,1,1,1
extracellular vesicles (EVs),8,0,0,0,0,0,0,0,0,1,0,2,2,3
integrins,8,0,2,0,0,0,0,1,0,1,0,2,1,1
Nrf2,8,0,0,0,0,0,0,0,1,1,1,1,2,2
vascular leakage,8,1,0,1,0,4,0,0,0,0,0,1,0,1
STAT3/STAT5,8,0,0,0,1,0,1,0,1,0,1,1,2,1
caspase-1/caspase-3/caspase-11,8,0,0,1,1,0,1,0,0,2,0,1,2,0
NOX/NOX1/NOX2/NOX4,8,0,1,0,1,0,0,1,1,1,1,1,1,0
mechanical ventilation,8,1,1,1,0,2,0,0,0,0,0,2,1,0
cyclic stretch,8,0,1,1,1,2,0,0,1,1,0,1,0,0
hyperpermeability,8,0,1,0,0,1,1,0,2,0,3,0,0,0
ERK/ERK1/ERK2,7,0,0,1,0,1,1,0,0,0,2,1,0,1
heparanase,7,0,0,0,0,0,2,0,2,0,1,1,0,1
exosomes,7,0,0,0,0,0,0,1,1,1,1,1,1,1
Akt/Akt1,7,0,0,0,0,0,0,0,1,1,1,2,1,1
endothelial barrier dysfunction,7,0,1,0,0,0,0,1,1,0,2,0,1,1
inflammatory cytokines,7,0,0,0,0,0,0,0,0,2,0,1,4,0
adhesion molecules,7,1,0,2,1,0,1,0,0,1,0,0,1,0
influenza,7,0,0,0,1,1,0,0,1,0,2,1,1,0
signal transduction,7,0,0,1,1,0,2,1,0,0,1,0,1,0
caveolin-1,7,1,0,0,1,0,0,2,0,0,1,1,1,0
angiotensin,7,0,0,1,0,1,2,1,1,0,0,1,0,0
MMP/MMP3/MMP9,7,0,1,0,0,0,0,1,1,1,0,3,0,0
Transient receptor potential vanilloid 4 (TRPV4),7,0,0,0,1,1,0,2,0,0,2,1,0,0
zonula occludens 1,7,0,0,1,0,1,0,0,2,0,3,0,0,0
biomarkers,7,0,2,1,0,1,0,1,0,0,2,0,0,0
barrier function,6,0,0,0,1,0,0,0,1,0,0,0,2,2
necroptosis,6,0,0,1,1,0,0,0,0,0,1,0,2,1
NLRP3,6,0,0,0,0,0,0,0,0,0,0,0,4,2
interleukin-6,6,1,1,0,1,0,0,1,0,0,1,0,0,1
heparin,6,0,0,0,1,0,0,0,1,1,1,0,2,0
hepatocyte growth factor (HGF),6,0,0,0,0,2,0,1,0,2,0,0,1,0
Rac1,6,0,0,0,0,1,1,0,0,1,0,2,1,0
claudin-5,6,0,0,0,0,0,0,0,1,1,1,2,1,0
PI3K,6,0,0,0,0,0,0,0,1,1,2,1,1,0
endothelial barrier function,6,0,0,0,1,0,0,1,0,0,2,2,0,0
c-Abl,6,1,0,0,1,3,0,0,0,0,1,0,0,0
Focal adhesion kinase (FAK),6,0,0,1,0,1,2,0,1,1,0,0,0,0
ferroptosis,5,0,0,0,0,0,0,0,0,0,0,0,2,3
macrophage,5,0,0,0,0,0,0,1,0,1,1,0,1,1
severe acute pancreatitis,5,0,0,0,1,0,2,0,0,0,0,0,0,2
neutrophil extracellular traps,5,0,0,0,0,0,1,0,0,1,1,1,0,1
lung inflammation,5,0,0,0,0,0,1,0,1,1,1,0,0,1
pulmonary fibrosis,5,0,0,0,0,0,0,1,0,0,0,1,2,1
HO-1,5,0,0,0,0,0,0,0,2,1,0,0,0,2
thrombosis,5,0,0,0,0,0,0,1,0,0,0,1,2,1
proteomics,5,0,1,1,0,2,0,0,0,0,0,0,1,0
complement,5,0,0,1,0,0,0,0,1,1,0,0,2,0
pneumolysin,5,0,0,1,0,0,0,2,1,0,0,0,1,0
transcription factor,5,0,0,1,1,1,1,0,0,0,0,0,1,0
mitochondria,5,0,0,0,0,0,0,0,1,1,1,1,1,0
HIF/HIF1 alpha,5,0,0,0,1,0,0,1,0,0,0,1,2,0
SIRT1,5,0,0,0,0,0,0,0,1,1,1,1,1,0
DAMPs,5,0,0,2,0,0,0,0,0,1,1,0,1,0
MPO,5,0,0,0,3,0,0,0,0,0,1,0,1,0
nanomedicine,5,0,0,1,0,1,0,0,0,0,0,2,1,0
hydrogen sulfide,5,1,0,1,0,0,0,0,1,0,1,0,1,0
drug delivery,5,0,0,0,0,2,0,0,1,0,0,2,0,0
microtubule,5,0,0,0,1,0,0,0,1,2,0,1,0,0
dexamethasone,5,0,0,0,0,0,0,1,1,1,1,1,0,0
siRNA,5,1,0,0,1,1,0,0,0,0,2,0,0,0
histone deacetylase 6,5,0,0,0,0,0,2,0,0,3,0,0,0,0
JNK,4,0,0,0,0,0,0,1,1,0,0,0,0,2
asthma,4,0,0,0,0,0,0,0,0,0,0,0,2,2
chronic obstructive pulmonary disease (COPD),4,0,0,0,0,0,0,0,0,0,0,1,1,2
neutrophil adhesion,4,0,0,1,0,0,0,0,0,1,0,0,0,2
alveolar epithelial cells,4,0,0,0,1,0,0,0,0,1,0,0,1,1
repair,4,0,0,0,0,0,1,1,0,0,0,0,1,1
ROCK1,4,0,0,0,0,0,0,0,0,2,0,0,1,1
injury,4,0,0,0,0,0,0,1,1,0,0,0,1,1
infection,4,0,0,1,0,0,1,0,0,0,0,1,1,0
acute pancreatitis,4,0,0,0,0,0,0,0,1,0,0,1,2,0
P53,4,0,0,0,0,0,0,0,1,2,0,0,0,1
microvesicle,4,0,0,0,0,0,0,0,1,1,0,1,1,0
mechanism,4,0,0,0,0,0,0,0,0,0,0,3,1,0
innate immunity,4,0,0,1,0,0,0,0,1,0,0,1,1,0
aquaporin 1,4,0,0,0,1,1,1,0,0,0,0,0,1,0
extracellular histones,4,0,0,0,0,0,1,1,0,0,0,0,2,0
Src,4,0,0,0,1,0,0,0,1,0,0,0,2,0
cortactin,4,0,0,0,1,1,0,0,0,0,0,0,2,0
fasudil,4,0,0,0,0,0,0,0,2,0,1,0,1,0
protein kinase C,4,0,0,0,1,1,0,0,0,0,0,1,1,0
Tie1/Tie2,4,0,0,1,0,0,1,0,1,0,0,0,1,0
cAMP,4,0,0,0,0,0,0,1,0,1,0,0,2,0
Staphylococcus aureus,4,0,0,0,0,0,0,1,0,2,0,0,1,0
chemokines,4,0,2,0,0,0,0,0,0,0,1,0,1,0
lung edema,4,1,0,0,0,2,0,0,0,0,0,1,0,0
cytokine storm,4,0,0,0,0,0,0,0,0,0,1,3,0,0
edema,4,0,0,3,0,0,0,0,0,0,0,1,0,0
endotoxemia,4,1,0,0,0,1,1,0,0,0,0,1,0,0
induced pluripotent stem cell,4,0,0,0,0,0,0,1,0,1,1,1,0,0
rat,4,0,1,0,0,0,1,0,0,0,1,1,0,0
vascular biology,4,0,0,0,0,0,1,0,0,1,2,0,0,0
"respiratory distress syndrome, adult",4,1,0,0,0,1,0,0,1,0,1,0,0,0
imatinib,4,0,0,0,0,3,0,0,0,0,1,0,0,0
hemorrhage,4,0,0,0,0,0,2,0,0,1,1,0,0,0
FTY720,4,1,0,0,0,0,2,0,0,0,1,0,0,0
interleukin-8,4,0,0,1,1,0,1,1,0,0,0,0,0,0
calcium,4,0,1,0,1,1,0,1,0,0,0,0,0,0
metformin,3,0,0,0,0,0,0,0,0,0,0,1,1,1
FoxO/FoxO1,3,0,0,0,0,0,0,0,0,1,0,0,1,1
hemorrhagic shock,3,0,0,0,0,0,0,1,0,0,0,0,1,1
gap junctions,3,1,0,0,0,0,0,0,1,0,0,0,0,1
FoxM1,3,0,0,0,1,0,0,0,0,0,0,0,1,1
endothelial-to-mesenchymal transition,3,0,0,0,0,0,1,1,0,0,0,0,0,1
plasminogen activator inhibitor 1,3,0,0,0,0,0,0,0,0,0,2,0,0,1
lipoxin A4,3,0,0,1,0,0,0,0,1,0,0,0,0,1
migration,3,0,0,1,0,0,0,0,1,0,0,0,1,0
lung targeting,3,0,0,0,0,0,0,1,0,1,0,0,1,0
AMPK,3,0,0,0,0,0,0,0,0,0,0,1,2,0
single-cell RNA sequencing,3,0,0,0,0,0,0,0,0,1,0,1,1,0
Sevoflurane,3,0,0,0,0,1,0,0,0,0,0,0,2,0
paraquat,3,0,0,1,0,0,0,0,1,0,0,0,1,0
mouse,3,0,0,0,0,0,0,0,0,1,1,0,1,0
endocytosis,3,0,0,0,0,1,1,0,0,0,0,0,1,0
histones,3,0,0,1,0,0,0,0,0,0,1,0,1,0
Thrombin,3,0,0,0,2,0,0,0,0,0,0,0,1,0
burn,3,0,0,0,0,0,0,0,0,0,2,0,1,0
vascular,3,0,0,0,0,0,1,0,1,0,0,0,1,0
renin-angiotensin system,3,0,0,1,0,0,0,0,0,1,0,0,1,0
PI3K/Akt pathway,3,0,0,0,1,0,0,0,0,0,1,0,1,0
CIRP,3,0,0,0,0,0,0,1,0,1,0,0,1,0
dipeptidyl peptidase-4,3,0,0,0,0,0,0,1,0,0,0,2,0,0
oxidized phospholipids,3,0,0,0,0,1,0,0,0,0,1,1,0,0
JAK2,3,0,0,0,0,0,1,0,1,0,0,0,1,0
heat stress,3,0,0,0,0,0,1,0,0,0,1,1,0,0
ALDH/ALDH2,3,0,0,0,0,0,0,0,1,1,0,1,0,0
hypoxia,3,0,0,1,0,1,0,0,0,0,0,1,0,0
Anti-inflammation,3,0,0,0,0,1,0,0,0,1,0,1,0,0
inflammasome,3,0,0,0,0,0,0,0,0,1,0,2,0,0
statins,3,0,1,0,1,0,0,0,0,0,0,1,0,0
treatment,3,0,1,0,0,0,0,0,0,0,0,2,0,0
Rap1,3,0,0,0,0,1,0,1,0,0,0,1,0,0
Arginine,3,0,0,0,0,1,0,0,0,0,1,1,0,0
MALAT1,3,0,0,0,0,0,0,0,1,0,1,1,0,0
respiratory infection,3,0,0,1,0,0,0,0,0,0,1,1,0,0
inflammatory response,3,0,0,0,0,0,0,0,0,0,2,1,0,0
cigarette smoke,3,0,0,0,0,0,1,0,1,0,1,0,0,0
BALF,3,0,0,1,0,0,0,0,1,0,1,0,0,0
pulmonary inflammation,3,0,0,0,1,1,0,0,0,0,1,0,0,0
Occludin,3,0,0,1,1,0,0,0,0,0,1,0,0,0
cadherin,3,0,0,1,0,0,0,0,0,0,2,0,0,0
ROCK,3,0,0,0,0,0,0,1,0,1,1,0,0,0
vascular inflammation,3,0,0,0,0,0,0,1,1,0,1,0,0,0
proliferation,3,0,0,0,0,0,1,0,0,1,1,0,0,0
platelet,3,0,1,0,1,0,0,0,0,0,1,0,0,0
lung disease,3,1,0,0,0,0,0,0,0,2,0,0,0,0
Rho/ROCK pathway,3,0,0,0,2,0,0,0,0,1,0,0,0,0
GEF-H1,3,0,0,0,0,0,0,1,1,1,0,0,0,0
simvastatin,3,0,0,0,0,0,0,2,0,1,0,0,0,0
gene therapy,3,0,0,0,1,1,0,0,0,1,0,0,0,0
seawater,3,0,0,0,1,0,0,1,1,0,0,0,0,0
F-actin,3,0,0,1,0,0,0,1,1,0,0,0,0,0
Endocan,3,0,0,1,0,0,0,0,2,0,0,0,0,0
pulmonary circulation,3,0,0,0,0,0,0,2,1,0,0,0,0,0
nicotinamide phosphoribosyltransferase,3,0,0,0,2,0,0,0,1,0,0,0,0,0
immune response,3,0,0,0,0,0,1,0,2,0,0,0,0,0
pulmonary hypertension,3,0,1,0,0,0,0,0,2,0,0,0,0,0
endotoxin,3,0,0,2,0,0,0,0,1,0,0,0,0,0
liposome,3,0,0,0,1,1,0,1,0,0,0,0,0,0
trauma,3,0,1,1,0,0,1,0,0,0,0,0,0,0
MLCK,3,0,0,1,1,1,0,0,0,0,0,0,0,0
microparticles,3,0,1,0,0,2,0,0,0,0,0,0,0,0
miR-223,2,0,0,0,0,0,0,0,0,0,0,0,1,1
fibrosis,2,0,0,0,0,0,0,0,1,0,0,0,0,1
Thr protein phosphatase 2A,2,0,0,0,0,0,0,0,0,0,0,0,0,2
microcirculation,2,0,0,0,0,0,0,0,0,0,0,0,0,2
phosphorylation,2,0,0,0,0,0,0,0,0,0,0,0,0,2
cardiopulmonary bypass,2,0,0,0,0,0,1,0,0,0,0,0,0,1
mesenteric lymph,2,0,0,0,0,0,0,0,0,0,1,0,0,1
histone deacetylase,2,0,0,0,0,0,0,0,0,0,0,0,1,1
mitochondrial transfer,2,0,0,0,0,0,0,0,0,1,0,0,0,1
oridonin,2,0,0,0,0,0,0,0,1,0,0,0,0,1
nanoparticles,2,0,0,0,0,0,0,0,0,1,0,0,0,1
alveolar macrophages,2,0,0,0,0,0,0,0,0,1,0,0,0,1
obesity,2,0,0,0,0,0,0,0,0,0,0,0,0,2
endothelial activation,2,0,0,0,0,0,0,0,0,1,0,0,0,1
connexins,2,1,0,0,0,0,0,0,0,0,0,0,0,1
monocyte,2,0,0,0,0,0,0,0,0,0,0,0,1,1
Cell damage,2,0,0,0,0,0,0,1,0,0,0,0,0,1
CCL2,2,0,0,0,0,0,0,0,0,1,0,0,0,1
apelin-13,2,0,0,0,0,0,0,0,0,0,0,1,0,1
Sivelestat,2,0,0,0,1,0,0,0,0,0,0,0,0,1
tocilizumab,2,0,0,0,0,0,0,0,0,0,1,0,0,1
Phospholipase D2,2,0,0,0,0,0,0,0,0,0,1,0,0,1
bronchopulmonary dysplasia,2,0,0,0,0,0,0,0,0,0,0,1,1,0
eCIRP,2,0,0,0,0,0,0,0,0,1,0,0,1,0
transmigration,2,0,0,0,0,0,0,0,0,1,0,0,1,0
HNA,2,0,0,0,0,0,0,0,1,0,0,0,1,0
non-coding RNA,2,0,0,0,0,0,0,0,0,0,0,0,2,0
HLA,2,0,0,0,0,0,0,0,1,0,0,0,1,0
Vasculature,2,0,0,0,0,0,0,0,0,0,1,0,1,0
epigenetics,2,0,0,0,0,0,1,0,0,0,0,0,1,0
polymorphonuclear neutrophil,2,0,0,0,1,0,0,0,0,0,0,0,1,0
radiation-induced lung injury,2,0,0,0,0,0,0,0,0,0,0,1,1,0
signaling pathway,2,0,0,0,0,0,0,0,0,0,0,1,1,0
acidosis,2,0,0,0,0,0,0,0,0,0,0,1,1,0
smoke inhalation,2,1,0,0,0,0,0,0,0,0,0,0,1,0
sickle cell disease,2,0,0,0,0,0,0,0,0,0,1,0,1,0
actin cytoskeleton,2,0,0,0,0,0,0,1,0,0,0,0,1,0
berberine,2,0,0,0,0,0,0,0,1,0,0,0,1,0
pulmonary biology,2,0,0,0,0,0,0,0,0,0,1,0,1,0
HSF1,2,0,0,0,0,0,0,0,0,0,1,0,1,0
endotheliitis,2,0,0,0,0,0,0,0,0,0,1,0,1,0
Ruscogenin,2,0,0,0,0,0,0,0,0,0,1,0,1,0
interaction,2,0,0,0,0,0,0,0,0,0,1,0,1,0
AKT/GSK3 beta signaling pathway,2,0,0,0,0,0,0,1,0,0,0,0,1,0
Targeted drug delivery,2,0,0,0,1,0,0,0,0,0,0,0,1,0
transcriptome,2,0,0,0,0,0,0,0,0,0,0,1,1,0
fibrin,2,0,0,0,0,0,0,0,0,0,1,0,1,0
lung function,2,0,0,0,0,0,1,0,0,0,0,0,1,0
vascular barrier,2,0,0,0,0,0,0,0,0,0,1,0,1,0
intermedin (IMD),2,0,0,0,0,0,0,0,0,0,1,0,1,0
vascular integrity,2,0,0,0,1,0,0,0,0,0,0,0,1,0
regeneration,2,0,0,0,0,0,1,0,0,0,0,0,1,0
lung cancer,2,0,0,0,0,0,0,0,0,1,0,0,1,0
review,2,0,0,0,0,0,1,0,0,0,0,0,1,0
chemotaxis,2,0,0,0,0,0,0,0,1,0,0,0,1,0
CD26,2,0,0,0,0,0,0,0,1,0,0,1,0,0
Epac,2,0,0,0,0,0,0,1,0,0,0,0,1,0
barrier dysfunction,2,0,0,0,0,1,0,0,0,0,0,1,0,0
EPCR,2,0,0,0,0,1,0,0,0,0,0,0,1,0
flow cytometry,2,1,0,0,0,0,0,0,0,0,0,1,0,0
Alda-1,2,0,0,0,0,0,0,0,0,1,0,1,0,0
metabolism,2,0,0,0,0,0,0,0,0,0,1,1,0,0
UCHL1,2,0,0,0,0,0,0,0,0,0,0,2,0,0
Acute kidney injury,2,0,0,1,0,0,0,0,0,0,0,1,0,0
immunothrombosis,2,0,0,0,0,0,0,1,0,0,0,1,0,0
Fluids,2,0,0,0,0,0,0,1,0,0,0,1,0,0
fibroblasts,2,0,0,0,0,0,0,0,0,1,0,1,0,0
Clinical trial,2,0,0,0,0,0,0,0,0,0,1,1,0,0
IQGAP1,2,0,0,0,0,0,0,0,0,0,1,1,0,0
lncRNA,2,0,0,0,0,0,0,0,0,0,0,2,0,0
Ezrin,2,0,0,0,0,0,0,0,0,0,0,2,0,0
epithelial cell,2,0,0,0,0,0,0,0,0,1,0,1,0,0
miRNA-181a-5p,2,0,0,0,0,0,0,0,0,0,1,1,0,0
Factor associated suicide,2,0,0,0,0,0,0,0,0,0,1,1,0,0
Pro-inflammatory factor,2,0,0,0,0,0,0,0,0,0,1,1,0,0
ERS,2,0,0,0,0,0,0,0,1,0,0,1,0,0
nitration,2,0,1,0,0,0,0,0,0,0,0,1,0,0
Endothelial damage,2,0,0,0,0,0,0,0,1,0,1,0,0,0
store-operated calcium entry,2,0,0,0,0,0,0,0,0,0,2,0,0,0
C5a,2,0,0,1,0,0,0,0,0,0,1,0,0,0
RAGE,2,1,0,0,0,0,0,0,0,0,1,0,0,0
Post-translational Modification,2,0,0,0,1,0,0,0,0,0,1,0,0,0
miR-92a,2,0,0,0,0,0,0,0,0,0,2,0,0,0
E-selectin-binding peptides,2,0,0,0,0,0,0,0,0,1,1,0,0,0
antiplatelet,2,0,0,0,1,0,0,0,0,0,1,0,0,0
therapy,2,0,0,0,0,0,0,0,0,0,2,0,0,0
cancer,2,0,0,0,0,0,0,0,0,1,1,0,0,0
RIP3,2,0,0,0,1,0,0,0,0,0,1,0,0,0
cell therapy,2,0,0,0,0,0,0,0,0,1,1,0,0,0
neovascularization,2,0,0,1,0,0,0,0,0,1,0,0,0,0
ERM,2,0,0,0,1,0,0,0,0,1,0,0,0,0
Unfractionated heparin,2,0,0,0,0,0,0,0,1,1,0,0,0,0
hirudin,2,0,0,0,1,0,0,0,0,1,0,0,0,0
RhoA/ROCK signaling pathway,2,0,0,0,0,1,0,0,0,1,0,0,0,0
Stem cell therapy,2,0,0,1,0,0,0,0,0,1,0,0,0,0
microvasculature,2,0,1,0,0,0,0,0,0,1,0,0,0,0
Connexin40,2,0,0,0,0,0,0,0,1,1,0,0,0,0
acrolein,2,0,0,0,0,0,0,1,1,0,0,0,0,0
ulinastatin,2,0,0,0,0,0,1,0,1,0,0,0,0,0
BML-111,2,0,0,0,0,0,1,0,1,0,0,0,0,0
MYLK,2,0,0,0,0,1,0,0,1,0,0,0,0,0
alpha(2)-adrenoreceptor,2,0,0,0,0,0,1,0,1,0,0,0,0,0
pneumococcal pneumonia,2,0,0,0,0,0,0,1,1,0,0,0,0,0
cre/loxp,2,1,0,0,0,0,0,0,1,0,0,0,0,0
vascular targeting,2,0,0,0,0,1,0,0,1,0,0,0,0,0
vascular disease,2,0,0,0,0,0,1,0,1,0,0,0,0,0
semaphorin 7A,2,0,0,0,1,0,0,1,0,0,0,0,0,0
malaria,2,0,0,0,1,0,0,1,0,0,0,0,0,0
acute aortic dissection,2,0,0,0,0,0,0,2,0,0,0,0,0,0
bone morphogenetic proteins,2,0,0,0,0,1,0,1,0,0,0,0,0,0
epithelial sodium channel,2,0,0,0,1,0,0,1,0,0,0,0,0,0
Pseudomonas aeruginosa,2,0,0,1,0,0,0,1,0,0,0,0,0,0
MCP-1,2,0,0,0,0,0,1,1,0,0,0,0,0,0
MK2,2,0,0,0,0,1,1,0,0,0,0,0,0,0
endothelial regeneration,2,0,0,1,0,0,1,0,0,0,0,0,0,0
primary graft dysfunction,2,0,0,0,0,1,1,0,0,0,0,0,0,0
thrombin,2,0,0,1,0,0,1,0,0,0,0,0,0,0
soluble adenylate cyclase,2,0,0,1,0,1,0,0,0,0,0,0,0,0
plasma,2,0,1,0,0,1,0,0,0,0,0,0,0,0
thrombomodulin,2,0,1,0,0,1,0,0,0,0,0,0,0,0
von Willebrand factor,2,0,1,0,0,1,0,0,0,0,0,0,0,0
lung transplantation,2,0,1,0,0,1,0,0,0,0,0,0,0,0
Hydrolyzing angiotensin II (AngII),2,0,0,0,0,2,0,0,0,0,0,0,0,0
inhalation,2,1,0,0,1,0,0,0,0,0,0,0,0,0
claudins,2,0,0,1,1,0,0,0,0,0,0,0,0,0
Fas,2,1,0,1,0,0,0,0,0,0,0,0,0,0
Technique,2,0,0,2,0,0,0,0,0,0,0,0,0,0
Basic science,2,0,0,2,0,0,0,0,0,0,0,0,0,0
Pathogen-associated molecular patterns (PAMPs),2,1,0,1,0,0,0,0,0,0,0,0,0,0
metalloproteinase,2,0,1,1,0,0,0,0,0,0,0,0,0,0
electron microscopy,2,1,1,0,0,0,0,0,0,0,0,0,0,0
Sema3A,1,0,0,0,0,0,0,0,0,0,0,0,0,1
inactive rhomboid-like protein 2,1,0,0,0,0,0,0,0,0,0,0,0,0,1
C-X3-C motif chemokine ligand 1,1,0,0,0,0,0,0,0,0,0,0,0,0,1
allogeneic bone marrow transplantation,1,0,0,0,0,0,0,0,0,0,0,0,0,1
murine model,1,0,0,0,0,0,0,0,0,0,0,0,0,1
ERR alpha,1,0,0,0,0,0,0,0,0,0,0,0,0,1
cofilin-1,1,0,0,0,0,0,0,0,0,0,0,0,0,1
sub-phenotypes,1,0,0,0,0,0,0,0,0,0,0,0,0,1
intensive care,1,0,0,0,0,0,0,0,0,0,0,0,0,1
Ser,1,0,0,0,0,0,0,0,0,0,0,0,0,1
Thr protein phosphatase 1,1,0,0,0,0,0,0,0,0,0,0,0,0,1
STEAP1,1,0,0,0,0,0,0,0,0,0,0,0,0,1
cell-derived extracellular vesicles,1,0,0,0,0,0,0,0,0,0,0,0,0,1
follistatin-like protein 1,1,0,0,0,0,0,0,0,0,0,0,0,0,1
Viola diffusa,1,0,0,0,0,0,0,0,0,0,0,0,0,1
protein processing,1,0,0,0,0,0,0,0,0,0,0,0,0,1
posttranslational,1,0,0,0,0,0,0,0,0,0,0,0,0,1
tripartite motif containing 37,1,0,0,0,0,0,0,0,0,0,0,0,0,1
ubiq-uitination,1,0,0,0,0,0,0,0,0,0,0,0,0,1
17 beta-estradiol,1,0,0,0,0,0,0,0,0,0,0,0,0,1
intestinal injury,1,0,0,0,0,0,0,0,0,0,0,0,0,1
Sirtuin,1,0,0,0,0,0,0,0,0,0,0,0,0,1
epithelial-mesenchymal transition (EMT),1,0,0,0,0,0,0,0,0,0,0,0,0,1
Diosmetin,1,0,0,0,0,0,0,0,0,0,0,0,0,1
alveolar capillary dysplasia,1,0,0,0,0,0,0,0,0,0,0,0,0,1
neonatal pulmonary disease,1,0,0,0,0,0,0,0,0,0,0,0,0,1
FOXF1,1,0,0,0,0,0,0,0,0,0,0,0,0,1
pulmonary angiogenesis,1,0,0,0,0,0,0,0,0,0,0,0,0,1
Permeability barrier,1,0,0,0,0,0,0,0,0,0,0,0,0,1
tunneling nanotube,1,0,0,0,0,0,0,0,0,0,0,0,0,1
Mitochondrial transcription factor A,1,0,0,0,0,0,0,0,0,0,0,0,0,1
CD31,1,0,0,0,0,0,0,0,0,0,0,0,0,1
Keap1,1,0,0,0,0,0,0,0,0,0,0,0,0,1
Jingfang granules,1,0,0,0,0,0,0,0,0,0,0,0,0,1
CD200-CD200R,1,0,0,0,0,0,0,0,0,0,0,0,0,1
transcriptomics,1,0,0,0,0,0,0,0,0,0,0,0,0,1
CD40L,1,0,0,0,0,0,0,0,0,0,0,0,0,1
Signal mechanism,1,0,0,0,0,0,0,0,0,0,0,0,0,1
Fatty acid synthase,1,0,0,0,0,0,0,0,0,0,0,0,0,1
Galectin,1,0,0,0,0,0,0,0,0,0,0,0,0,1
Neuraminidase,1,0,0,0,0,0,0,0,0,0,0,0,0,1
Desialylation,1,0,0,0,0,0,0,0,0,0,0,0,0,1
PMN extravasation,1,0,0,0,0,0,0,0,0,0,0,0,0,1
ADSCs exosome,1,0,0,0,0,0,0,0,0,0,0,0,0,1
GPX4,1,0,0,0,0,0,0,0,0,0,0,0,0,1
FGFR1,1,0,0,0,0,0,0,0,0,0,0,0,0,1
ROCK2,1,0,0,0,0,0,0,0,0,0,0,0,0,1
hemoglobin,1,0,0,0,0,0,0,0,0,0,0,0,0,1
leukocyte adhesion,1,0,0,0,0,0,0,0,0,0,0,0,0,1
therapeutic targets,1,0,0,0,0,0,0,0,0,0,0,0,0,1
airway diseases,1,0,0,0,0,0,0,0,0,0,0,0,0,1
chronic rhinosinusitis,1,0,0,0,0,0,0,0,0,0,0,0,0,1
cystic fibrosis,1,0,0,0,0,0,0,0,0,0,0,0,0,1
bronchiectasis,1,0,0,0,0,0,0,0,0,0,0,0,0,1
EGFR,1,0,0,0,0,0,0,0,0,0,0,0,0,1
flowmotion,1,0,0,0,0,0,0,0,0,0,0,0,0,1
Mg supplementation,1,0,0,0,0,0,0,0,0,0,0,0,0,1
PWV Analysis,1,0,0,0,0,0,0,0,0,0,0,0,0,1
RAAS,1,0,0,0,0,0,0,0,0,0,0,0,0,1
CoV-2,1,0,0,0,0,0,0,0,0,0,0,0,0,1
vasomotion,1,0,0,0,0,0,0,0,0,0,0,0,0,1
lysophosphatidic acid,1,0,0,0,0,0,0,0,0,0,0,0,0,1
survival and homing,1,0,0,0,0,0,0,0,0,0,0,0,0,1
receptor subtype-specific mechanism,1,0,0,0,0,0,0,0,0,0,0,0,0,1
Ceramide,1,0,0,0,0,0,0,0,0,0,0,0,0,1
Txnip,1,0,0,0,0,0,0,0,0,0,0,0,0,1
Decursinol angelate,1,0,0,0,0,0,0,0,0,0,0,0,0,1
large conductance K+ channels,1,0,0,0,0,0,0,0,0,0,0,0,0,1
L-type voltage-gated Ca2+ channels,1,0,0,0,0,0,0,0,0,0,0,0,0,1
Nifedipine,1,0,0,0,0,0,0,0,0,0,0,0,0,1
NS1619,1,0,0,0,0,0,0,0,0,0,0,0,0,1
pathway analysis,1,0,0,0,0,0,0,0,0,0,0,0,0,1
Isopropyl 3-(3,1,0,0,0,0,0,0,0,0,0,0,0,0,1
4-dihydroxyphenyl)-2-hydroxypropanoate,1,0,0,0,0,0,0,0,0,0,0,0,0,1
small RNA,1,0,0,0,0,0,0,0,0,0,0,0,0,1
cell-free microRNAs,1,0,0,0,0,0,0,0,0,0,0,0,0,1
tetramethylpyrazine,1,0,0,0,0,0,0,0,0,0,0,0,0,1
pulmonary capillary,1,0,0,0,0,0,0,0,0,0,0,0,0,1
circKlhl2,1,0,0,0,0,0,0,0,0,0,0,0,0,1
miR-29b-3p,1,0,0,0,0,0,0,0,0,0,0,0,0,1
TGF-beta 1,1,0,0,0,0,0,0,0,0,0,0,0,0,1
P- selectin,1,0,0,0,0,0,0,0,0,0,0,0,0,1
SELPLG promoter activity,1,0,0,0,0,0,0,0,0,0,0,0,0,1
TSGL-Ig,1,0,0,0,0,0,0,0,0,0,0,0,0,1
decursin,1,0,0,0,0,0,0,0,0,0,0,0,0,1
acute lung,1,0,0,0,0,0,0,0,0,0,0,0,0,1
BAP31,1,0,0,0,0,0,0,0,0,0,0,0,0,1
Neutrophil-endothelium adhesion,1,0,0,0,0,0,0,0,0,0,0,0,0,1
MyD88,1,0,0,0,0,0,0,0,0,0,0,0,0,1
TRAF6-mediated pathway,1,0,0,0,0,0,0,0,0,0,0,0,0,1
endothelial niche,1,0,0,0,0,0,0,0,0,0,0,0,1,0
pulmonary hypoplasia,1,0,0,0,0,0,0,0,0,0,0,0,1,0
translational outcome,1,0,0,0,0,0,0,0,0,0,0,0,1,0
metabolic syndrome,1,0,0,0,0,0,0,0,0,0,0,0,0,1
Steen solution,1,0,0,0,0,0,0,0,0,0,0,0,0,1
in vivo lung perfusion,1,0,0,0,0,0,0,0,0,0,0,0,0,1
HTS,1,0,0,0,0,0,0,0,0,0,0,0,1,0
high throughput satellite,1,0,0,0,0,0,0,0,0,0,0,0,1,0
Trogocytosis,1,0,0,0,0,0,0,0,0,0,0,0,1,0
oxygen oscillations,1,0,0,0,0,0,0,0,0,0,0,0,1,0
enrichment analysis,1,0,0,0,0,0,0,0,0,0,0,0,1,0
SNHG3,1,0,0,0,0,0,0,0,0,0,0,0,0,1
miR-186-5p,1,0,0,0,0,0,0,0,0,0,0,0,0,1
Wnt,1,0,0,0,0,0,0,0,0,0,0,0,0,1
circWDR33,1,0,0,0,0,0,0,0,0,0,0,0,1,0
miR-217-5p,1,0,0,0,0,0,0,0,0,0,0,0,1,0
SERP1,1,0,0,0,0,0,0,0,0,0,0,0,1,0
?B),1,0,0,0,0,0,0,0,0,0,0,0,1,0
Hyaluronan,1,0,0,0,0,0,0,0,0,0,0,0,1,0
Community-acquired pneumonia,1,0,0,0,0,0,0,0,0,0,0,0,1,0
heparin-binding protein (HBP),1,0,0,0,0,0,0,0,0,0,0,0,1,0
transforming growth factor-beta receptor type 2 (TGF-beta-R2),1,0,0,0,0,0,0,0,0,0,0,0,1,0
targeted therapy,1,0,0,0,0,0,0,0,0,0,0,0,1,0
diagnosis,1,0,0,0,0,0,0,0,0,0,0,0,1,0
parthanatos,1,0,0,0,0,0,0,0,0,0,0,0,1,0
SRPK1,1,0,0,0,0,0,0,0,0,0,0,0,0,1
NLRP3 inflammasome,1,0,0,0,0,0,0,0,0,0,0,0,0,1
pulmonary epithelial cell,1,0,0,0,0,0,0,0,0,0,0,0,1,0
Growth hormone-releasing hormone,1,0,0,0,0,0,0,0,0,0,0,0,0,1
circPalm2,1,0,0,0,0,0,0,0,0,0,0,0,1,0
miR-450b-5p,1,0,0,0,0,0,0,0,0,0,0,0,1,0
FGF5,1,0,0,0,0,0,0,0,0,0,0,0,1,0
Cytoprotection,1,0,0,0,0,0,0,0,0,0,0,0,0,1
Human pulmonary microvascular,1,0,0,0,0,0,0,0,0,0,0,0,0,1
clopidogrel,1,0,0,0,0,0,0,0,0,0,0,0,1,0
P2Y12 receptor,1,0,0,0,0,0,0,0,0,0,0,0,1,0
ticagrelor,1,0,0,0,0,0,0,0,0,0,0,0,1,0
lung inflammatory injury,1,0,0,0,0,0,0,0,0,0,0,0,1,0
citrulline,1,0,0,0,0,0,0,0,0,0,0,0,1,0
NOD-,1,0,0,0,0,0,0,0,0,0,0,0,1,0
LRR- and pyrin domain-containing protein 3 inflammasome,1,0,0,0,0,0,0,0,0,0,0,0,1,0
LncRNA H19,1,0,0,0,0,0,0,0,0,0,0,0,1,0
miR-107,1,0,0,0,0,0,0,0,0,0,0,0,1,0
TGFBR3,1,0,0,0,0,0,0,0,0,0,0,0,1,0
Linagliptin,1,0,0,0,0,0,0,0,0,0,0,0,1,0
Epac1,1,0,0,0,0,0,0,0,0,0,0,0,1,0
melatonin,1,0,0,0,0,0,0,0,0,0,0,0,1,0
Organ interaction,1,0,0,0,0,0,0,0,0,0,0,0,1,0
Semaglutide,1,0,0,0,0,0,0,0,0,0,0,0,1,0
HDAC5,1,0,0,0,0,0,0,0,0,0,0,0,1,0
two-hit model,1,0,0,0,0,0,0,0,0,0,0,0,1,0
endothelial adhesion molecules,1,0,0,0,0,0,0,0,0,0,0,0,1,0
inflammatory signaling,1,0,0,0,0,0,0,0,0,0,0,0,1,0
microRNA-374a-5p,1,0,0,0,0,0,0,0,0,0,0,0,1,0
zinc finger E-box binding homeobox 1,1,0,0,0,0,0,0,0,0,0,0,0,1,0
TEM,1,0,0,0,0,0,0,0,0,0,0,0,1,0
Unfolded protein response,1,0,0,0,0,0,0,0,0,0,0,0,1,0
transcriptional repression,1,0,0,0,0,0,0,0,0,0,0,0,1,0
Human leukocyte antigen-A2,1,0,0,0,0,0,0,0,0,0,0,0,1,0
Apelin-APJ axis,1,0,0,0,0,0,0,0,0,0,0,0,1,0
Endothelial mesenchymal transition,1,0,0,0,0,0,0,0,0,0,0,0,1,0
acute inflammation of lung injury,1,0,0,0,0,0,0,0,0,0,0,0,1,0
intercellular communication networks,1,0,0,0,0,0,0,0,0,0,0,0,1,0
radiosensitivity,1,0,0,0,0,0,0,0,0,0,0,0,1,0
endothelial pyroptosis,1,0,0,0,0,0,0,0,0,0,0,0,1,0
Blebbistatin,1,0,0,0,0,0,0,0,0,0,0,0,1,0
Non-muscle myosin IIA,1,0,0,0,0,0,0,0,0,0,0,0,1,0
acidic microenvironment,1,0,0,0,0,0,0,0,0,0,0,0,1,0
aerobic glycolysis,1,0,0,0,0,0,0,0,0,0,0,0,1,0
lung capillaries,1,0,0,0,0,0,0,0,0,0,0,0,1,0
Tranilast,1,0,0,0,0,0,0,0,0,0,0,0,1,0
circEXOC5,1,0,0,0,0,0,0,0,0,0,0,0,1,0
Adipose-derived stem cells,1,0,0,0,0,0,0,0,0,0,0,0,1,0
Small extracellular vesicles,1,0,0,0,0,0,0,0,0,0,0,0,1,0
acute chest syndrome,1,0,0,0,0,0,0,0,0,0,0,0,1,0
hemin,1,0,0,0,0,0,0,0,0,0,0,0,1,0
matory responses,1,0,0,0,0,0,0,0,0,0,0,0,1,0
Unc-51 like autophagy activating kinase 1,1,0,0,0,0,0,0,0,0,0,0,0,1,0
Protective autophagy,1,0,0,0,0,0,0,0,0,0,0,0,1,0
rabeprazole,1,0,0,0,0,0,0,0,0,0,0,0,1,0
calcium channels,1,0,0,0,0,0,0,0,0,0,0,0,1,0
CX3CL1-CX3CR1 axis,1,0,0,0,0,0,0,0,0,0,0,0,1,0
soluble fractalkine,1,0,0,0,0,0,0,0,0,0,0,0,1,0
ADAM10,1,0,0,0,0,0,0,0,0,0,0,0,1,0
LINC00839,1,0,0,0,0,0,0,0,0,0,0,0,1,0
Verdiperstat,1,0,0,0,0,0,0,0,0,0,0,0,1,0
-Calpain,1,0,0,0,0,0,0,0,0,0,0,0,1,0
p-Catenin,1,0,0,0,0,0,0,0,0,0,0,0,1,0
C3a-C3aR,1,0,0,0,0,0,0,0,0,0,0,0,1,0
lncRNA NORAD,1,0,0,0,0,0,0,0,0,0,0,0,1,0
miR-30c-5p,1,0,0,0,0,0,0,0,0,0,0,0,1,0
glucose metabolism,1,0,0,0,0,0,0,0,0,0,0,0,1,0
LDHA,1,0,0,0,0,0,0,0,0,0,0,0,1,0
mTOR,1,0,0,0,0,0,0,0,0,0,0,0,1,0
poisoning,1,0,0,0,0,0,0,0,0,0,0,0,1,0
SET gene,1,0,0,0,0,0,0,0,0,0,0,0,1,0
miR-199,1,0,0,0,0,0,0,0,0,0,0,0,1,0
Hypercoagulopathy,1,0,0,0,0,0,0,0,0,0,0,0,1,0
PV-1,1,0,0,0,0,0,0,0,0,0,0,0,1,0
Non-muscle myosin heavy chain IIA,1,0,0,0,0,0,0,0,0,0,0,0,1,0
bitter taste receptors,1,0,0,0,0,0,0,0,0,0,0,0,1,0
Ghrelin,1,0,0,0,0,0,0,0,0,0,0,0,1,0
Pharmacokinetics,1,0,0,0,0,0,0,0,0,0,0,0,1,0
porcine reproductive and respiratory syndrome virus (PRRSV),1,0,0,0,0,0,0,0,0,0,0,0,1,0
transwell co-cultures,1,0,0,0,0,0,0,0,0,0,0,0,1,0
MG53,1,0,0,0,0,0,0,0,0,0,0,0,1,0
nitrogen mustard,1,0,0,0,0,0,0,0,0,0,0,0,1,0
lncRNA OIP5-AS1,1,0,0,0,0,0,0,0,0,0,0,0,1,0
kindlin-2,1,0,0,0,0,0,0,0,0,0,0,0,1,0
diffuse alveolar damage score,1,0,0,0,0,0,0,0,0,0,0,0,1,0
molecular biology,1,0,0,0,0,0,0,0,0,0,0,0,1,0
IFN gamma,1,0,0,0,0,0,0,0,0,0,0,0,1,0
lung epithelial cells,1,0,0,0,0,0,0,0,0,0,0,0,1,0
MLKL,1,0,0,0,0,0,0,0,0,0,0,0,1,0
Receptor interacting protein 140 (RIP140),1,0,0,0,0,0,0,0,0,0,0,0,1,0
C-terminal binding protein 2 (CTBP2),1,0,0,0,0,0,0,0,0,0,0,0,1,0
JAK-STAT signaling pathway,1,0,0,0,0,0,0,0,0,0,0,0,1,0
endoglin (Eng),1,0,0,0,0,0,0,0,0,0,0,0,1,0
Notch pathway,1,0,0,0,0,0,0,0,0,0,0,0,1,0
Nicotinamide adenine dinucleotide phosphate oxidase 4,1,0,0,0,0,0,0,0,0,0,0,0,1,0
Dexamethasone nanoparticles,1,0,0,0,0,0,0,0,0,0,0,0,1,0
targeted drugs,1,0,0,0,0,0,0,0,0,0,0,0,1,0
respiratory system,1,0,0,0,0,0,0,0,0,0,0,0,1,0
pulmonary disease,1,0,0,0,0,0,0,0,0,0,0,0,1,0
polymorphism,1,0,0,0,0,0,0,0,0,0,0,0,1,0
pulmonary sarcoidosis,1,0,0,0,0,0,0,0,0,0,0,0,1,0
Polyphyllin I,1,0,0,0,0,0,0,0,0,0,0,0,1,0
tissue factor,1,0,0,0,0,0,0,0,0,0,0,0,1,0
beas-2b,1,0,0,0,0,0,0,0,0,0,0,0,1,0
cxcl3,1,0,0,0,0,0,0,0,0,0,0,0,1,0
CCL25,1,0,0,0,0,0,0,0,0,0,0,0,1,0
CCR11,1,0,0,0,0,0,0,0,0,0,0,0,1,0
Raltegravir,1,0,0,0,0,0,0,0,0,0,0,0,1,0
Claudin-18,1,0,0,0,0,0,0,0,0,0,0,0,1,0
1,1,0,0,0,0,0,0,0,0,0,0,0,1,0
Ramelteon,1,0,0,0,0,0,0,0,0,0,0,0,1,0
Ferulic acid,1,0,0,0,0,0,0,0,0,0,0,0,1,0
miR-17,1,0,0,0,0,0,0,0,0,0,0,0,1,0
PTEN,1,0,0,0,0,0,0,0,0,0,0,0,1,0
chronic bronchitis,1,0,0,0,0,0,0,0,0,0,0,0,1,0
STING,1,0,0,0,0,0,0,0,0,0,0,0,1,0
Xuebijing Injection,1,0,0,0,0,0,0,0,0,0,0,0,1,0
dauricine,1,0,0,0,0,0,0,0,0,0,0,1,0,0
prostaglandin F-2 alpha (PGF(2 alpha)),1,0,0,0,0,0,0,0,0,0,0,1,0,0
anagliptin,1,0,0,0,0,0,0,0,0,0,0,1,0,0
terbutaline,1,0,0,0,0,0,0,0,0,0,0,0,1,0
airway epithelium,1,0,0,0,0,0,0,0,0,0,0,1,0,0
preconditioning,1,0,0,0,0,0,0,0,0,0,0,1,0,0
OxPAPC,1,0,0,0,0,0,0,0,0,0,0,1,0,0
receptor,1,0,0,0,0,0,0,0,0,0,0,1,0,0
mineralocorticoid receptor,1,0,0,0,0,0,0,0,0,0,0,1,0,0
spironolactone and dexamethasone,1,0,0,0,0,0,0,0,0,0,0,1,0,0
whole lung tissue engineering,1,0,0,0,0,0,0,0,0,0,0,1,0,0
pulmonary vasculature,1,0,0,0,0,0,0,0,0,0,0,1,0,0
in vitro disease modeling,1,0,0,0,0,0,0,0,0,0,0,1,0,0
Isoorientin,1,0,0,0,0,0,0,0,0,0,0,0,1,0
Intensive care unit,1,0,0,0,0,0,0,0,0,0,0,1,0,0
Postoperative period,1,0,0,0,0,0,0,0,0,0,0,1,0,0
Outcome,1,0,0,0,0,0,0,0,0,0,0,1,0,0
noncanonical TERT,1,0,0,0,0,0,0,0,0,0,0,1,0,0
pulmonary injury,1,0,0,0,0,0,0,0,0,0,0,1,0,0
type 2 alveolar epithelial cell,1,0,0,0,0,0,0,0,0,0,0,1,0,0
heatstroke,1,0,0,0,0,0,0,0,0,0,0,1,0,0
signaling,1,0,0,0,0,0,0,0,0,0,0,1,0,0
Mitochondrial biogenesis,1,0,0,0,0,0,0,0,0,0,0,1,0,0
sulfur dioxide,1,0,0,0,0,0,0,0,0,0,0,1,0,0
pathophysiology,1,0,0,0,0,0,0,0,0,0,0,1,0,0
ISM1,1,0,0,0,0,0,0,0,0,0,0,1,0,0
Targeting strategy,1,0,0,0,0,0,0,0,0,0,0,1,0,0
Pathophysiologic feature,1,0,0,0,0,0,0,0,0,0,0,1,0,0
cell culture model for lung transplantation,1,0,0,0,0,0,0,0,0,0,0,1,0,0
transcriptomics and bioinformatics,1,0,0,0,0,0,0,0,0,0,0,1,0,0
functional genomics,1,0,0,0,0,0,0,0,0,0,0,1,0,0
translational research,1,0,0,0,0,0,0,0,0,0,0,1,0,0
interleukin-10,1,0,0,0,0,0,0,0,0,0,0,1,0,0
sartans,1,0,0,0,0,0,0,0,0,0,0,1,0,0
Dehydrozingerone,1,0,0,0,0,0,0,0,0,0,0,1,0,0
Elastase,1,0,0,0,0,0,0,0,0,0,0,1,0,0
haloperidol,1,0,0,0,0,0,0,0,0,0,0,1,0,0
Nur77,1,0,0,0,0,0,0,0,0,0,0,1,0,0
IFN regulatory factor 1,1,0,0,0,0,0,0,0,0,0,0,1,0,0
ANDV,1,0,0,0,0,0,0,0,0,0,0,1,0,0
RhoGDI,1,0,0,0,0,0,0,0,0,0,0,1,0,0
hantavirus,1,0,0,0,0,0,0,0,0,0,0,1,0,0
nucleocapsid,1,0,0,0,0,0,0,0,0,0,0,1,0,0
hand,1,0,0,0,0,0,0,0,0,0,0,1,0,0
foot,1,0,0,0,0,0,0,0,0,0,0,1,0,0
and mouth disease,1,0,0,0,0,0,0,0,0,0,0,1,0,0
Coxsackievirus A2,1,0,0,0,0,0,0,0,0,0,0,1,0,0
Pravastatin,1,0,0,0,0,0,0,0,0,0,0,1,0,0
APOM,1,0,0,0,0,0,0,0,0,0,0,0,1,0
propofol,1,0,0,0,0,0,0,0,0,0,0,0,1,0
miR-128-3p,1,0,0,0,0,0,0,0,0,0,0,1,0,0
PEL12,1,0,0,0,0,0,0,0,0,0,0,1,0,0
MIR3142HG,1,0,0,0,0,0,0,0,0,0,0,1,0,0
spike protein,1,0,0,0,0,0,0,0,0,0,0,1,0,0
Long non-coding RNA cardiac hypertrophy-related factor (lncRNA CHRF),1,0,0,0,0,0,0,0,0,0,0,1,0,0
pulmonary function,1,0,0,0,0,0,0,0,0,0,0,1,0,0
HSPA12A,1,0,0,0,0,0,0,0,0,0,0,1,0,0
PEEP,1,0,0,0,0,0,0,0,0,0,0,1,0,0
Kidney,1,0,0,0,0,0,0,0,0,0,0,1,0,0
Heart,1,0,0,0,0,0,0,0,0,0,0,1,0,0
eXpress Permeability Test (XPerT),1,0,0,0,0,0,0,0,0,0,0,1,0,0
image cytometry,1,0,0,0,0,0,0,0,0,0,0,1,0,0
Celigo,1,0,0,0,0,0,0,0,0,0,0,1,0,0
Respiratory virus,1,0,0,0,0,0,0,0,0,0,0,1,0,0
epithelial-endothelial barrier,1,0,0,0,0,0,0,0,0,0,0,1,0,0
PCTR1,1,0,0,0,0,0,0,0,0,0,0,1,0,0
EXT-1,1,0,0,0,0,0,0,0,0,0,0,1,0,0
proteome,1,0,0,0,0,0,0,0,0,0,0,1,0,0
gVPLA(2),1,0,0,0,0,0,0,0,0,0,0,1,0,0
sPLA(2)-V,1,0,0,0,0,0,0,0,0,0,0,1,0,0
PLA(2)G5,1,0,0,0,0,0,0,0,0,0,0,1,0,0
secretory phospholipase A(2),1,0,0,0,0,0,0,0,0,0,0,1,0,0
bacterial infection,1,0,0,0,0,0,0,0,0,0,0,1,0,0
intravital microscopy,1,0,0,0,0,0,0,0,0,0,0,1,0,0
MRSA,1,0,0,0,0,0,0,0,0,0,0,1,0,0
USA300,1,0,0,0,0,0,0,0,0,0,0,1,0,0
MERS-CoV,1,0,0,0,0,0,0,0,0,0,0,1,0,0
primary human lung cells,1,0,0,0,0,0,0,0,0,0,0,1,0,0
unfolded protein response,1,0,0,0,0,0,0,0,0,0,0,1,0,0
sACE2,1,0,0,0,0,0,0,0,0,0,0,1,0,0
adrenomedullin,1,0,0,0,0,0,0,0,0,0,0,1,0,0
XIST,1,0,0,0,0,0,0,0,0,0,0,1,0,0
hydrochloric acid,1,0,0,0,0,0,0,0,0,0,0,1,0,0
HCl,1,0,0,0,0,0,0,0,0,0,0,1,0,0
heat shock protein,1,0,0,0,0,0,0,0,0,0,0,1,0,0
HSP90 inhibition,1,0,0,0,0,0,0,0,0,0,0,1,0,0
AUY-922,1,0,0,0,0,0,0,0,0,0,0,1,0,0
BMP9,1,0,0,0,0,0,0,0,0,0,0,1,0,0
BMP signaling in endothelial cells,1,0,0,0,0,0,0,0,0,0,0,1,0,0
LIF,1,0,0,0,0,0,0,0,0,0,0,1,0,0
neutrophil transendothelial migration,1,0,0,0,0,0,0,0,0,0,0,1,0,0
SB203580,1,0,0,0,0,0,0,0,0,0,0,1,0,0
inflammatory immune response,1,0,0,0,0,0,0,0,0,0,0,1,0,0
molecular mechanism,1,0,0,0,0,0,0,0,0,0,0,1,0,0
Ubiquitin-specific protease 18,1,0,0,0,0,0,0,0,0,0,0,1,0,0
cells,1,0,0,0,0,0,0,0,0,0,0,1,0,0
human,1,0,0,0,0,0,0,0,0,0,0,1,0,0
non-human primate,1,0,0,0,0,0,0,0,0,0,0,1,0,0
co-culture,1,0,0,0,0,0,0,0,0,0,0,1,0,0
TUNEL assay,1,0,0,0,0,0,0,0,0,0,0,1,0,0
KLF7,1,0,0,0,0,0,0,0,0,0,0,1,0,0
methylation,1,0,0,0,0,0,0,0,0,0,0,1,0,0
Piezo1,1,0,0,0,0,0,0,0,0,0,0,1,0,0
Ca2+,1,0,0,0,0,0,0,0,0,0,0,1,0,0
Dual-Specificity Phosphatases,1,0,0,0,0,0,0,0,0,0,0,1,0,0
expression profile,1,0,0,0,0,0,0,0,0,0,0,1,0,0
MMP1,1,0,0,0,0,0,0,0,0,0,0,1,0,0
TNFAIP3,1,0,0,0,0,0,0,0,0,0,0,1,0,0
Abl2,1,0,0,0,0,0,0,0,0,0,0,1,0,0
MitoQ,1,0,0,0,0,0,0,0,0,0,0,1,0,0
microRNA-877-5p,1,0,0,0,0,0,0,0,0,0,0,1,0,0
(Cyclin-dependent kinase inhibitor 1B),1,0,0,0,0,0,0,0,0,0,0,1,0,0
CDKN1B,1,0,0,0,0,0,0,0,0,0,0,1,0,0
Cdk2,1,0,0,0,0,0,0,0,0,0,0,1,0,0
Midkine,1,0,0,0,0,0,0,0,0,0,0,1,0,0
Inflammasome activation,1,0,0,0,0,0,0,0,0,0,0,1,0,0
p-Coumaric acid,1,0,0,0,0,0,0,0,0,0,0,1,0,0
In silico study,1,0,0,0,0,0,0,0,0,0,0,1,0,0
Cisatracurium,1,0,0,0,0,0,0,0,0,0,0,1,0,0
cell junction,1,0,0,0,0,0,0,0,0,0,0,1,0,0
mitochondrial dysfunction,1,0,0,0,0,0,0,0,0,0,0,1,0,0
large conductance potassium channels,1,0,0,0,0,0,0,0,0,0,0,1,0,0
respiratory disease,1,0,0,0,0,0,0,0,0,0,0,1,0,0
Cell survival,1,0,0,0,0,0,0,0,0,0,0,1,0,0
RBM3,1,0,0,0,0,0,0,0,0,0,0,1,0,0
Circ_0054633,1,0,0,0,0,0,0,0,0,0,0,1,0,0
NE-kappa B,1,0,0,0,0,0,0,0,0,0,0,1,0,0
Btk,1,0,0,0,0,0,0,0,0,0,0,1,0,0
Orai 1,1,0,0,0,0,0,0,0,0,0,0,1,0,0
Calcium signal,1,0,0,0,0,0,0,0,0,0,0,1,0,0
Endothelial cells-derived exosome,1,0,0,0,0,0,0,0,0,0,0,1,0,0
MicroRNA-125b-5p,1,0,0,0,0,0,0,0,0,0,0,1,0,0
Topoisomerase II alpha,1,0,0,0,0,0,0,0,0,0,0,1,0,0
DJ-1,1,0,0,0,0,0,0,0,0,0,0,1,0,0
PARK7,1,0,0,0,0,0,0,0,0,0,0,1,0,0
Pulmonary pathology,1,0,0,0,0,0,0,0,0,0,0,1,0,0
Molecular pathology,1,0,0,0,0,0,0,0,0,0,0,1,0,0
DAD,1,0,0,0,0,0,0,0,0,0,0,1,0,0
LncRNA MALAT1,1,0,0,0,0,0,0,0,0,0,0,1,0,0
XBP-1S,1,0,0,0,0,0,0,0,0,0,0,1,0,0
XBP-1U,1,0,0,0,0,0,0,0,0,0,0,1,0,0
miR-490,1,0,0,0,0,0,0,0,0,0,0,1,0,0
MRP4,1,0,0,0,0,0,0,0,0,0,0,1,0,0
HOXB4,1,0,0,0,0,0,0,0,0,0,0,1,0,0
phospholipid scramblase 4 (PLSCR4),1,0,0,0,0,0,0,0,0,0,0,1,0,0
gasdermin D (GSDMD),1,0,0,0,0,0,0,0,0,0,0,1,0,0
PKC alpha,1,0,0,0,0,0,0,0,0,0,0,1,0,0
Mitochondrial bioenergetics,1,0,0,0,0,0,0,0,0,0,0,1,0,0
gypenosides,1,0,0,0,0,0,0,0,0,0,0,1,0,0
sulfatase 2,1,0,0,0,0,0,0,0,0,0,0,1,0,0
miR-204-3p,1,0,0,0,0,0,0,0,0,0,0,1,0,0
Adipose-derived mesenchymal stem cells,1,0,0,0,0,0,0,0,0,0,1,0,0,0
miR-126,1,0,0,0,0,0,0,0,0,0,1,0,0,0
Immunomodulation,1,0,0,0,0,0,0,0,0,0,1,0,0,0
ACE-2 receptor,1,0,0,0,0,0,0,0,0,0,1,0,0,0
Lung fibrosis,1,0,0,0,0,0,0,0,0,0,1,0,0,0
heme,1,0,0,0,0,0,0,0,0,0,1,0,0,0
electric cell-substrate impedance sensing,1,0,0,0,0,0,0,0,0,0,1,0,0,0
hemopexin,1,0,0,0,0,0,0,0,0,0,1,0,0,0
Na+,1,0,0,0,0,0,0,0,0,0,1,0,0,0
H+ exchanger,1,0,0,0,0,0,0,0,0,0,1,0,0,0
Rhamnocitrin,1,0,0,0,0,0,0,0,0,0,1,0,0,0
Endothelial cell inflammation,1,0,0,0,0,0,0,0,0,0,1,0,0,0
Calcineurin/NFATc3,1,0,0,0,0,0,0,0,0,0,1,0,0,0
PIM1,1,0,0,0,0,0,0,0,0,0,0,1,0,0
ELK3,1,0,0,0,0,0,0,0,0,0,0,1,0,0
FGF2,1,0,0,0,0,0,0,0,0,0,1,0,0,0
fat embolism syndrome,1,0,0,0,0,0,0,0,0,0,1,0,0,0
ursodeoxycholic acid,1,0,0,0,0,0,0,0,0,0,1,0,0,0
HDL dysfunction,1,0,0,0,0,0,0,0,0,0,1,0,0,0
PI3K/Akt/eNOS,1,0,0,0,0,0,0,0,0,0,1,0,0,0
dysfunction,1,0,0,0,0,0,0,0,0,0,1,0,0,0
mitochondrial fission/fusion,1,0,0,0,0,0,0,0,0,0,1,0,0,0
mitophagy,1,0,0,0,0,0,0,0,0,0,1,0,0,0
&#945,1,0,0,0,0,0,0,0,0,0,1,0,0,0
1-antitrypsin,1,0,0,0,0,0,0,0,0,0,1,0,0,0
34-1-2S,1,0,0,0,0,0,0,0,0,0,1,0,0,0
osteopontin,1,0,0,0,0,0,0,0,0,0,1,0,0,0
miRNA-451,1,0,0,0,0,0,0,0,0,0,1,0,0,0
eukaryotic elongation factor 2,1,0,0,0,0,0,0,0,0,0,1,0,0,0
miR-642a-5p,1,0,0,0,0,0,0,0,0,0,1,0,0,0
miR-330-5p,1,0,0,0,0,0,0,0,0,0,0,1,0,0
PRNCR1,1,0,0,0,0,0,0,0,0,0,0,1,0,0
C-Jun,1,0,0,0,0,0,0,0,0,0,1,0,0,0
lncRNA THRIL,1,0,0,0,0,0,0,0,0,0,1,0,0,0
albumin,1,0,0,0,0,0,0,0,0,0,1,0,0,0
transcytosis,1,0,0,0,0,0,0,0,0,0,1,0,0,0
endothelial-barrier function,1,0,0,0,0,0,0,0,0,0,1,0,0,0
GSK2798745,1,0,0,0,0,0,0,0,0,0,1,0,0,0
Segmental lipopolysaccharide (LPS) challenge,1,0,0,0,0,0,0,0,0,0,1,0,0,0
Urea-correction,1,0,0,0,0,0,0,0,0,0,1,0,0,0
Vascular endothelial dysfunction,1,0,0,0,0,0,0,0,0,0,1,0,0,0
Systemic inflammatory response,1,0,0,0,0,0,0,0,0,0,1,0,0,0
Kawasaki disease shock syndrome,1,0,0,0,0,0,0,0,0,0,1,0,0,0
barrier protection,1,0,0,0,0,0,0,0,0,0,0,1,0,0
Class IIA HDACs inhibition,1,0,0,0,0,0,0,0,0,0,0,1,0,0
TMP269,1,0,0,0,0,0,0,0,0,0,0,1,0,0
Hyaluronic,1,0,0,0,0,0,0,0,0,0,1,0,0,0
intestinal ischemia,1,0,0,0,0,0,0,0,0,0,1,0,0,0
C16,1,0,0,0,0,0,0,0,0,0,1,0,0,0
cytokine release syndrome,1,0,0,0,0,0,0,0,0,0,1,0,0,0
p22phox,1,0,0,0,0,0,0,0,0,0,1,0,0,0
p47phox,1,0,0,0,0,0,0,0,0,0,1,0,0,0
miR-122-5p,1,0,0,0,0,0,0,0,0,0,1,0,0,0
DUSP4,1,0,0,0,0,0,0,0,0,0,1,0,0,0
Akt/mTOR signal pathway,1,0,0,0,0,0,0,0,0,0,1,0,0,0
2-chlorofatty acid,1,0,0,0,0,0,0,0,0,0,1,0,0,0
mast cell activation,1,0,0,0,0,0,0,0,0,0,1,0,0,0
proinflammatory mediators,1,0,0,0,0,0,0,0,0,0,1,0,0,0
Soluble cluster of differentiation 74,1,0,0,0,0,0,0,0,0,0,1,0,0,0
systemic disease,1,0,0,0,0,0,0,0,0,0,0,1,0,0
virus,1,0,0,0,0,0,0,0,0,0,1,0,0,0
tolerance,1,0,0,0,0,0,0,0,0,0,1,0,0,0
thiourea,1,0,0,0,0,0,0,0,0,0,1,0,0,0
flavin-containing monooxygenase,1,0,0,0,0,0,0,0,0,0,1,0,0,0
endoplasmic reticulum-plasma membrane junctions,1,0,0,0,0,0,0,0,0,0,1,0,0,0
long myosin light chain kinase,1,0,0,0,0,0,0,0,0,0,1,0,0,0
stromal interacting molecule 1,1,0,0,0,0,0,0,0,0,0,1,0,0,0
polymer micelles,1,0,0,0,0,0,0,0,0,0,1,0,0,0
cationic polymer,1,0,0,0,0,0,0,0,0,0,1,0,0,0
drug targeting,1,0,0,0,0,0,0,0,0,0,1,0,0,0
blood-brain barrier,1,0,0,0,0,0,0,0,0,0,1,0,0,0
interleukin-1 beta,1,0,0,0,0,0,0,0,0,0,1,0,0,0
hypercapnia,1,0,0,0,0,0,0,0,0,0,1,0,0,0
hypoxemia,1,0,0,0,0,0,0,0,0,0,1,0,0,0
aspirin,1,0,0,0,0,0,0,0,0,0,1,0,0,0
basic science research,1,0,0,0,0,0,0,0,0,0,1,0,0,0
cell biology,1,0,0,0,0,0,0,0,0,0,1,0,0,0
critical care,1,0,0,0,0,0,0,0,0,0,1,0,0,0
fibrinolysis,1,0,0,0,0,0,0,0,0,0,1,0,0,0
tissue plasminogen activator,1,0,0,0,0,0,0,0,0,0,1,0,0,0
leukocytes,1,0,0,0,0,0,0,0,0,0,1,0,0,0
phosphotyrosine signaling,1,0,0,0,0,0,0,0,0,0,1,0,0,0
lipid signaling,1,0,0,0,0,0,0,0,0,0,1,0,0,0
endothelial barrier restoration,1,0,0,0,0,0,0,0,0,0,1,0,0,0
phosphatidic acid signaling,1,0,0,0,0,0,0,0,0,0,1,0,0,0
protein tyrosine phosphatase non-receptor type 14 (PTPN14),1,0,0,0,0,0,0,0,0,0,1,0,0,0
Luteolin,1,0,0,0,0,0,0,0,0,0,1,0,0,0
Kaempferol,1,0,0,0,0,0,0,0,0,0,1,0,0,0
Pulmonary barrier dysfunction,1,0,0,0,0,0,0,0,0,0,1,0,0,0
Phytochemicals,1,0,0,0,0,0,0,0,0,0,1,0,0,0
pulmonary microvascular endothelium barrier,1,0,0,0,0,0,0,0,0,0,1,0,0,0
RNA-Seq,1,0,0,0,0,0,0,0,0,0,1,0,0,0
Pristimerin,1,0,0,0,0,0,0,0,0,0,1,0,0,0
lung adenocarcinoma transcript 1,1,0,0,0,0,0,0,0,0,0,1,0,0,0
microRNA-150-5p,1,0,0,0,0,0,0,0,0,0,1,0,0,0
endothelial biology,1,0,0,0,0,0,0,0,0,0,1,0,0,0
phospholipidomics,1,0,0,0,0,0,0,0,0,0,1,0,0,0
aging,1,0,0,0,0,0,0,0,0,0,1,0,0,0
co-inhibitory receptor,1,0,0,0,0,0,0,0,0,0,1,0,0,0
adipose-derived exosomes,1,0,0,0,0,0,0,0,0,0,1,0,0,0
Antioxidant response element,1,0,0,0,0,0,0,0,0,0,1,0,0,0
Sulforaphane,1,0,0,0,0,0,0,0,0,0,1,0,0,0
PEAR1,1,0,0,0,0,0,0,0,0,0,1,0,0,0
Crocin,1,0,0,0,0,0,0,0,0,0,1,0,0,0
Glycocalyx damage,1,0,0,0,0,0,0,0,0,0,1,0,0,0
GAB1,1,0,0,0,0,0,0,0,0,0,1,0,0,0
TUG1,1,0,0,0,0,0,0,0,0,0,1,0,0,0
Chaperone heat shock protein 90,1,0,0,0,0,0,0,0,0,0,1,0,0,0
p23,1,0,0,0,0,0,0,0,0,0,1,0,0,0
MCTR1,1,0,0,0,0,0,0,0,0,0,1,0,0,0
Hydrogen-rich medium,1,0,0,0,0,0,0,0,0,0,1,0,0,0
Paracrine effects,1,0,0,0,0,0,0,0,0,0,1,0,0,0
GSTpi,1,0,0,0,0,0,0,0,0,0,1,0,0,0
Src/VE-Cadherin pathway,1,0,0,0,0,0,0,0,0,0,1,0,0,0
S-Glutathionylation of Src,1,0,0,0,0,0,0,0,0,0,1,0,0,0
citrullinated histone H3,1,0,0,0,0,0,0,0,0,0,1,0,0,0
endotoxic shock,1,0,0,0,0,0,0,0,0,0,1,0,0,0
new anti-CitH3 antibody,1,0,0,0,0,0,0,0,0,0,1,0,0,0
survival,1,0,0,0,0,0,0,0,0,0,1,0,0,0
regioisomer,1,0,0,0,0,0,0,0,0,0,1,0,0,0
miR-483-5p,1,0,0,0,0,0,0,0,0,0,1,0,0,0
PIAS1,1,0,0,0,0,0,0,0,0,0,1,0,0,0
SIRT3,1,0,0,0,0,0,0,0,0,0,1,0,0,0
ITGA5,1,0,0,0,0,0,0,0,0,0,1,0,0,0
CLP sepsis,1,0,0,0,0,0,0,0,0,0,1,0,0,0
IGFBP7,1,0,0,0,0,0,0,0,0,0,1,0,0,0
miR-29a,1,0,0,0,0,0,0,0,0,0,1,0,0,0
Telocyte,1,0,0,0,0,0,0,0,0,1,0,0,0,0
miRNA-21a-3p,1,0,0,0,0,0,0,0,0,1,0,0,0,0
laboratory animals,1,0,0,0,0,0,0,0,0,0,1,0,0,0
ubiquitin E3 ligase,1,0,0,0,0,0,0,0,0,1,0,0,0,0
PGC-1 alpha mitochondria biogenesis,1,0,0,0,0,0,0,0,0,1,0,0,0,0
adipokine,1,0,0,0,0,0,0,0,0,1,0,0,0,0
complement activation,1,0,0,0,0,0,0,0,0,1,0,0,0,0
disseminated intravascular coagulation (DIC),1,0,0,0,0,0,0,0,0,1,0,0,0,0
disseminated intravascular microthrombosis (DIT),1,0,0,0,0,0,0,0,0,1,0,0,0,0
endotheliopathy,1,0,0,0,0,0,0,0,0,1,0,0,0,0
endotheliopathy-associated vascular microthrombotic disease (EA-VMTD),1,0,0,0,0,0,0,0,0,1,0,0,0,0
hemostatic disorder,1,0,0,0,0,0,0,0,0,1,0,0,0,0
microthrombogenesis,1,0,0,0,0,0,0,0,0,1,0,0,0,0
multi-organ dysfunction syndrome (MODS),1,0,0,0,0,0,0,0,0,1,0,0,0,0
TTP-like syndrome,1,0,0,0,0,0,0,0,0,1,0,0,0,0
vascular microthrombotic disease (VMTD),1,0,0,0,0,0,0,0,0,1,0,0,0,0
genistein-3 '-sodium sulphonate,1,0,0,0,0,0,0,0,0,0,1,0,0,0
TIMP-1,1,0,0,0,0,0,0,0,0,1,0,0,0,0
Syndecan-1,1,0,0,0,0,0,0,0,0,1,0,0,0,0
p190RhoGAP,1,0,0,0,0,0,0,0,0,1,0,0,0,0
Lung development,1,0,0,0,0,0,0,0,0,1,0,0,0,0
bovine serum albumin nanoparticles,1,0,0,0,0,0,0,0,0,1,0,0,0,0
targeting ability,1,0,0,0,0,0,0,0,0,1,0,0,0,0
alveolar remodeling,1,0,0,0,0,0,0,0,0,1,0,0,0,0
MyD88 acetylation,1,0,0,0,0,0,0,0,0,1,0,0,0,0
Mas receptor,1,0,0,0,0,0,0,0,0,1,0,0,0,0
miR-144,1,0,0,0,0,0,0,0,0,1,0,0,0,0
PFKFB3,1,0,0,0,0,0,0,0,0,1,0,0,0,0
Glycolysis,1,0,0,0,0,0,0,0,0,1,0,0,0,0
chemokine receptors,1,0,0,0,0,0,0,0,0,1,0,0,0,0
PI-PLC,1,0,0,0,0,0,0,0,0,1,0,0,0,0
tissue damage,1,0,0,0,0,0,0,0,0,1,0,0,0,0
SND,1,0,0,0,0,0,0,0,0,1,0,0,0,0
PI3K/AKT/mTOR pathway,1,0,0,0,0,0,0,0,0,1,0,0,0,0
lipocalin-type prostaglandin D synthase,1,0,0,0,0,0,0,0,0,1,0,0,0,0
CO2-removal,1,0,0,0,0,0,0,0,0,1,0,0,0,0
wearability,1,0,0,0,0,0,0,0,0,1,0,0,0,0
hemocompatibility,1,0,0,0,0,0,0,0,0,1,0,0,0,0
surface modification,1,0,0,0,0,0,0,0,0,1,0,0,0,0
endothelialization,1,0,0,0,0,0,0,0,0,1,0,0,0,0
NAD(P)H: quinine oxidoreductase-1,1,0,0,0,0,0,0,0,0,1,0,0,0,0
MK571,1,0,0,0,0,0,0,0,0,1,0,0,0,0
Retinal arterioles,1,0,0,0,0,0,0,0,0,1,0,0,0,0
Ciliary arteries,1,0,0,0,0,0,0,0,0,1,0,0,0,0
Reverse D-4F,1,0,0,0,0,0,0,0,0,1,0,0,0,0
Apolipoprotein A-I,1,0,0,0,0,0,0,0,0,1,0,0,0,0
Tetramethylpyrazine,1,0,0,0,0,0,0,0,0,1,0,0,0,0
Cell transplantation,1,0,0,0,0,0,0,0,0,1,0,0,0,0
anticoagulants,1,0,0,0,0,0,0,0,0,1,0,0,0,0
human tissue factor pathway inhibitor (hTFPI),1,0,0,0,0,0,0,0,0,1,0,0,0,0
regulatory T-cells,1,0,0,0,0,0,0,0,0,1,0,0,0,0
T helper cell immune responses,1,0,0,0,0,0,0,0,0,1,0,0,0,0
SRT1720,1,0,0,0,0,0,0,0,0,1,0,0,0,0
EX527,1,0,0,0,0,0,0,0,0,1,0,0,0,0
Y-27632,1,0,0,0,0,0,0,0,0,1,0,0,0,0
Slit2,1,0,0,0,0,0,0,0,0,1,0,0,0,0
Robo4,1,0,0,0,0,0,0,0,0,1,0,0,0,0
focal adhesion,1,0,0,0,0,0,0,0,0,1,0,0,0,0
mechanical stress,1,0,0,0,0,0,0,0,0,1,0,0,0,0
Bioprocessing,1,0,0,0,0,0,0,0,0,1,0,0,0,0
Viability,1,0,0,0,0,0,0,0,0,1,0,0,0,0
Differentiation,1,0,0,0,0,0,0,0,0,1,0,0,0,0
Donor variability,1,0,0,0,0,0,0,0,0,1,0,0,0,0
hypercapnic acidosis,1,0,0,0,0,0,0,0,0,1,0,0,0,0
wound healing,1,0,0,0,0,0,0,0,0,1,0,0,0,0
miR-34a,1,0,0,0,0,0,0,0,0,1,0,0,0,0
mitochondrial-mediated apoptosis,1,0,0,0,0,0,0,0,0,1,0,0,0,0
M2 macrophages,1,0,0,0,0,0,0,0,0,1,0,0,0,0
MJ33,1,0,0,0,0,0,0,0,0,1,0,0,0,0
mutant Prdx6,1,0,0,0,0,0,0,0,0,1,0,0,0,0
Prdx6 phosphorylation,1,0,0,0,0,0,0,0,0,1,0,0,0,0
aureus),1,0,0,0,0,0,0,0,0,1,0,0,0,0
barrier disruption,1,0,0,0,0,0,0,0,0,1,0,0,0,0
CLASP2,1,0,0,0,0,0,0,0,0,1,0,0,0,0
mTOR/STAT3 pathway,1,0,0,0,0,0,0,0,0,1,0,0,0,0
Lycium barbarum polysaccharide,1,0,0,0,0,0,0,0,0,1,0,0,0,0
bacterial lipopolysaccharide,1,0,0,0,0,0,0,0,0,1,0,0,0,0
evans blue,1,0,0,0,0,0,0,0,0,1,0,0,0,0
tissue factor pathway inhibitor,1,0,0,0,0,0,0,0,0,1,0,0,0,0
SU5416,1,0,0,0,0,0,0,0,0,1,0,0,0,0
curcumin,1,0,0,0,0,0,0,0,0,1,0,0,0,0
mitochondrial targeting,1,0,0,0,0,0,0,0,0,1,0,0,0,0
sialic acid,1,0,0,0,0,0,0,0,0,1,0,0,0,0
microsphere,1,0,0,0,0,0,0,0,0,1,0,0,0,0
Particulate matter,1,0,0,0,0,0,0,0,0,1,0,0,0,0
brain injury,1,0,0,0,0,0,0,0,0,1,0,0,0,0
miR-33 and RIP140,1,0,0,0,0,0,0,0,0,1,0,0,0,0
viral vector,1,0,0,0,0,0,0,0,0,1,0,0,0,0
nonviral vector,1,0,0,0,0,0,0,0,0,1,0,0,0,0
Pulmonary vascular endothelium-targeting,1,0,0,0,0,0,0,0,1,0,0,0,0,0
Dexamethasone delivery,1,0,0,0,0,0,0,0,1,0,0,0,0,0
Surface charge,1,0,0,0,0,0,0,0,1,0,0,0,0,0
Inflammatory regulation,1,0,0,0,0,0,0,0,1,0,0,0,0,0
Monocyte adhesion,1,0,0,0,0,0,0,0,1,0,0,0,0,0
Cell cytoskeleton,1,0,0,0,0,0,0,0,1,0,0,0,0,0
myosin,1,0,0,0,0,0,0,0,1,0,0,0,0,0
DPP4 inhibitor,1,0,0,0,0,0,0,0,1,0,0,0,0,0
sitagliptin,1,0,0,0,0,0,0,0,1,0,0,0,0,0
rhodopsin,1,0,0,0,0,0,0,0,1,0,0,0,0,0
Bleomycin,1,0,0,0,0,0,0,0,1,0,0,0,0,0
Omentin-1,1,0,0,0,0,0,0,0,1,0,0,0,0,0
stanniocalcin,1,0,0,0,0,0,0,0,0,1,0,0,0,0
tobacco,1,0,0,0,0,0,0,0,1,0,0,0,0,0
paracellular permeability,1,0,0,0,0,0,0,0,1,0,0,0,0,0
telocytes,1,0,0,0,0,0,0,0,1,0,0,0,0,0
EOMA,1,0,0,0,0,0,0,0,1,0,0,0,0,0
heterogeneity,1,0,0,0,0,0,0,0,1,0,0,0,0,0
Matrigel,1,0,0,0,0,0,0,0,1,0,0,0,0,0
network formation,1,0,0,0,0,0,0,0,1,0,0,0,0,0
SLC-0111,1,0,0,0,0,0,0,0,1,0,0,0,0,0
Cell apoptosis,1,0,0,0,0,0,0,0,1,0,0,0,0,0
NAD(+),1,0,0,0,0,0,0,0,1,0,0,0,0,0
Circulatory extracellular vesicles,1,0,0,0,0,0,0,0,1,0,0,0,0,0
Runx1 isoforms,1,0,0,0,0,0,0,0,1,0,0,0,0,0
Alk5,1,0,0,0,0,0,0,0,1,0,0,0,0,0
Hsp70,1,0,0,0,0,0,0,0,1,0,0,0,0,0
C5aR1 inhibition,1,0,0,0,0,0,0,0,1,0,0,0,0,0
Mitochondrial UPR,1,0,0,0,0,0,0,0,1,0,0,0,0,0
Cellular bioenergetics,1,0,0,0,0,0,0,0,1,0,0,0,0,0
substrate stiffness,1,0,0,0,0,0,0,0,1,0,0,0,0,0
emphysema,1,0,0,0,0,0,0,0,1,0,0,0,0,0
splicing,1,0,0,0,0,0,0,0,1,0,0,0,0,0
heterogeneous nuclear ribonucleoprotein A1,1,0,0,0,0,0,0,0,1,0,0,0,0,0
Acacetin,1,0,0,0,0,0,0,0,1,0,0,0,0,0
sphingosine kinase 1,1,0,0,0,0,0,0,0,1,0,0,0,0,0
airway inflammation,1,0,0,0,0,0,0,0,1,0,0,0,0,0
theta defensin,1,0,0,0,0,0,0,0,1,0,0,0,0,0
host defense peptide,1,0,0,0,0,0,0,0,1,0,0,0,0,0
Prognosis,1,0,0,0,0,0,0,0,1,0,0,0,0,0
rhAPC,1,0,0,0,0,0,0,0,1,0,0,0,0,0
lung vascular injury,1,0,0,0,0,0,0,0,1,0,0,0,0,0
neferine,1,0,0,0,0,0,0,0,1,0,0,0,0,0
Pulmonary microvascular injury and repair,1,0,0,0,0,0,0,0,1,0,0,0,0,0
Cdc42,1,0,0,0,0,0,0,0,1,0,0,0,0,0
PAK1/AKT pathway,1,0,0,0,0,0,0,0,1,0,0,0,0,0
histone deacetylase inhibitors,1,0,0,0,0,0,0,0,1,0,0,0,0,0
HMGB1/TLR-4,1,0,0,0,0,0,0,0,1,0,0,0,0,0
Indinavir,1,0,0,0,0,0,0,0,1,0,0,0,0,0
methylprednisolone,1,0,0,0,0,0,0,0,1,0,0,0,0,0
two-hit ALI,1,0,0,0,0,0,0,0,1,0,0,0,0,0
NETosis,1,0,0,0,0,0,0,0,1,0,0,0,0,0
CLP,1,0,0,0,0,0,0,0,1,0,0,0,0,0
TER,1,0,0,0,0,0,0,0,1,0,0,0,0,0
LBP,1,0,0,0,0,0,0,0,1,0,0,0,0,0
anti-apoptosis,1,0,0,0,0,0,0,0,1,0,0,0,0,0
antioxidant,1,0,0,0,0,0,0,0,1,0,0,0,0,0
Paracrine,1,0,0,0,0,0,0,0,1,0,0,0,0,0
ATG16L1,1,0,0,0,0,0,0,0,1,0,0,0,0,0
CDH5,1,0,0,0,0,0,0,0,1,0,0,0,0,0
RAB26 GTPase,1,0,0,0,0,0,0,0,1,0,0,0,0,0
Kir2.1,1,0,0,0,0,0,0,0,1,0,0,0,0,0
mitochondrial transmembrane potential,1,0,0,0,0,0,0,0,1,0,0,0,0,0
artificial sweetener,1,0,0,0,0,0,0,0,1,0,0,0,0,0
sweet taste,1,0,0,0,0,0,0,0,1,0,0,0,0,0
T1R3,1,0,0,0,0,0,0,0,1,0,0,0,0,0
EndoMT,1,0,0,0,0,0,0,0,1,0,0,0,0,0
Antibodies,1,0,0,0,0,0,0,0,1,0,0,0,0,0
Transendothelial migration,1,0,0,0,0,0,0,0,1,0,0,0,0,0
Cellular adhesion molecules,1,0,0,0,0,0,0,0,1,0,0,0,0,0
exercise immunology,1,0,0,0,0,0,0,0,1,0,0,0,0,0
Tripterygium hypoglaucum,1,0,0,0,0,0,0,0,1,0,0,0,0,0
root extract,1,0,0,0,0,0,0,0,1,0,0,0,0,0
lung barrier function,1,0,0,0,0,0,0,0,1,0,0,0,0,0
factor Xa,1,0,0,0,0,0,0,0,1,0,0,0,0,0
rivaroxaban,1,0,0,0,0,0,0,0,1,0,0,0,0,0
microvascular barrier,1,0,0,0,0,0,0,0,1,0,0,0,0,0
Saquinavir,1,0,0,0,0,0,0,0,1,0,0,0,0,0
Two-hit,1,0,0,0,0,0,0,0,1,0,0,0,0,0
PKC pathway,1,0,0,0,0,0,0,0,1,0,0,0,0,0
miR-124,1,0,0,0,0,0,0,1,0,0,0,0,0,0
transcript regulation,1,0,0,0,0,0,0,1,0,0,0,0,0,0
macrophage polarization,1,0,0,0,0,0,0,1,0,0,0,0,0,0
mitochondrial aldehyde dehydrogenase 2,1,0,0,0,0,0,0,1,0,0,0,0,0,0
mitochondrial respiration,1,0,0,0,0,0,0,1,0,0,0,0,0,0
vaspin,1,0,0,0,0,0,0,1,0,0,0,0,0,0
PKA,1,0,0,0,0,0,0,1,0,0,0,0,0,0
Vasculotide,1,0,0,0,0,0,0,1,0,0,0,0,0,0
Acute ethanol intoxication,1,0,0,0,0,0,0,1,0,0,0,0,0,0
Pentraxin 3,1,0,0,0,0,0,0,1,0,0,0,0,0,0
Growth arrest-specific gene 6 (Gas6),1,0,0,0,0,0,0,1,0,0,0,0,0,0
Post ARDS pulmonary fibrosis,1,0,0,0,0,0,0,1,0,0,0,0,0,0
ELISA,1,0,0,0,0,0,0,1,0,0,0,0,0,0
Plasma,1,0,0,0,0,0,0,1,0,0,0,0,0,0
C23,1,0,0,0,0,0,0,1,0,0,0,0,0,0
plexin C1,1,0,0,0,0,0,0,1,0,0,0,0,0,0
beta 1 integrin,1,0,0,0,0,0,0,1,0,0,0,0,0,0
Mesenchymal stem cells microvesicles,1,0,0,0,0,0,0,1,0,0,0,0,0,0
glucocorticoids,1,0,0,0,0,0,0,1,0,0,0,0,0,0
interferon-gamma,1,0,0,0,0,0,0,1,0,0,0,0,0,0
Systemic inflammation,1,0,0,0,0,0,0,1,0,0,0,0,0,0
Lung mechanics,1,0,0,0,0,0,0,1,0,0,0,0,0,0
Surfactants,1,0,0,0,0,0,0,1,0,0,0,0,0,0
"0.9% saline, angiopoietin 2, P-selectin",1,0,0,0,0,0,0,1,0,0,0,0,0,0
Aquaporins,1,0,0,0,0,0,0,1,0,0,0,0,0,0
bindarit,1,0,0,0,0,0,0,1,0,0,0,0,0,0
GSK-3beta,1,0,0,0,0,0,0,1,0,0,0,0,0,0
atherosclerosis,1,0,0,0,0,0,0,1,0,0,0,0,0,0
oxygen-glucose deprivation/oxygen-glucose restoration,1,0,0,0,0,0,0,1,0,0,0,0,0,0
non-selective cation channel,1,0,0,0,0,0,0,1,0,0,0,0,0,0
lipoxins,1,0,0,0,0,0,0,1,0,0,0,0,0,0
phospholipids,1,0,0,0,0,0,0,1,0,0,0,0,0,0
mtDNA repair,1,0,0,0,0,0,0,1,0,0,0,0,0,0
A549,1,0,0,0,0,0,0,1,0,0,0,0,0,0
T cells,1,0,0,0,0,0,0,1,0,0,0,0,0,0
CD54,1,0,0,0,0,0,0,1,0,0,0,0,0,0
Animal models,1,0,0,0,0,0,0,1,0,0,0,0,0,0
Lentiviral vector,1,0,0,0,0,0,0,1,0,0,0,0,0,0
Cell signalling,1,0,0,0,0,0,0,1,0,0,0,0,0,0
Paraquat,1,0,0,0,0,0,0,1,0,0,0,0,0,0
c-Src,1,0,0,0,0,0,0,1,0,0,0,0,0,0
TGF-beta signaling,1,0,0,0,0,0,0,1,0,0,0,0,0,0
vascular remodeling,1,0,0,0,0,0,0,1,0,0,0,0,0,0
nanotechnology,1,0,0,0,0,0,0,1,0,0,0,0,0,0
nanocarrier,1,0,0,0,0,0,0,1,0,0,0,0,0,0
RNA interference,1,0,0,0,0,0,0,1,0,0,0,0,0,0
transcriptional regulation,1,0,0,0,0,0,0,1,0,0,0,0,0,0
mechanical forces,1,0,0,0,0,0,0,1,0,0,0,0,0,0
S-nitrosylation,1,0,0,0,0,0,0,1,0,0,0,0,0,0
G(+)-toxins,1,0,0,0,0,0,0,1,0,0,0,0,0,0
GTPase,1,0,0,0,0,0,0,1,0,0,0,0,0,0
exchange factor directly activated by cyclic adenosine monophosphate,1,0,0,0,0,0,0,1,0,0,0,0,0,0
senescence,1,0,0,0,0,0,0,1,0,0,0,0,0,0
endothelial microparticles,1,0,0,0,0,0,0,1,0,0,0,0,0,0
Arp 2/3,1,0,0,0,0,0,0,1,0,0,0,0,0,0
endothelial barrier regulation,1,0,0,0,0,0,0,1,0,0,0,0,0,0
cytoskeletal dynamics,1,0,0,0,0,0,0,1,0,0,0,0,0,0
lamellipodia,1,0,0,0,0,0,0,1,0,0,0,0,0,0
Heat shock protein A12B,1,0,0,0,0,0,0,1,0,0,0,0,0,0
target genes,1,0,0,0,0,0,0,1,0,0,0,0,0,0
alveolar fluid clearance,1,0,0,0,0,0,0,1,0,0,0,0,0,0
amiloride-insensitive sodium channel,1,0,0,0,0,0,0,1,0,0,0,0,0,0
concentration-sensitive sodium channel,1,0,0,0,0,0,0,1,0,0,0,0,0,0
human umbilical cord mesenchymal stem cell,1,0,0,0,0,0,0,1,0,0,0,0,0,0
nanostructured lipid carrier,1,0,0,0,0,0,0,1,0,0,0,0,0,0
simvastatin delivery,1,0,0,0,0,0,0,1,0,0,0,0,0,0
collapse,1,0,0,0,0,0,0,1,0,0,0,0,0,0
KCa3.1,1,0,0,0,0,0,0,1,0,0,0,0,0,0
lung oedema,1,0,0,0,0,0,0,1,0,0,0,0,0,0
promoter activity,1,0,0,0,0,0,0,1,0,0,0,0,0,0
KLF2,1,0,0,0,0,0,0,1,0,0,0,0,0,0
Beta-arrestin-1 penehyclidine hydrochloride,1,0,0,0,0,0,0,1,0,0,0,0,0,0
shRNA,1,0,0,0,0,0,0,1,0,0,0,0,0,0
Acute pulmonary endothelial cell injury,1,0,0,0,0,0,1,0,0,0,0,0,0,0
DNA methylation,1,0,0,0,0,0,1,0,0,0,0,0,0,0
epigenetic modifiers,1,0,0,0,0,0,1,0,0,0,0,0,0,0
histone acetylation,1,0,0,0,0,0,1,0,0,0,0,0,0,0
extracellular matrix,1,0,0,0,0,0,1,0,0,0,0,0,0,0
cathepsin B,1,0,0,0,0,0,1,0,0,0,0,0,0,0
Yes-associated protein,1,0,0,0,0,0,1,0,0,0,0,0,0,0
P73,1,0,0,0,0,0,1,0,0,0,0,0,0,0
Stanford type-A acute aortic dissection,1,0,0,0,0,0,1,0,0,0,0,0,0,0
iron chelators,1,0,0,0,0,0,1,0,0,0,0,0,0,0
morphology,1,0,0,0,0,0,1,0,0,0,0,0,0,0
AFM,1,0,0,0,0,0,1,0,0,0,0,0,0,0
Barrier regulation,1,0,0,0,0,0,1,0,0,0,0,0,0,0
Lysosome,1,0,0,0,0,0,1,0,0,0,0,0,0,0
dexmedetomidine,1,0,0,0,0,0,1,0,0,0,0,0,0,0
Pathology Section,1,0,0,0,0,0,1,0,0,0,0,0,0,0
Cytochrome P450,1,0,0,0,0,0,1,0,0,0,0,0,0,0
CYP1B1,1,0,0,0,0,0,1,0,0,0,0,0,0,0
cell culture,1,0,0,0,0,0,1,0,0,0,0,0,0,0
Calpain,1,0,0,0,0,0,1,0,0,0,0,0,0,0
CXCR3,1,0,0,0,0,0,1,0,0,0,0,0,0,0
Astilbin,1,0,0,0,0,0,1,0,0,0,0,0,0,0
extravasated platelet aggregation (EPA),1,0,0,0,0,0,1,0,0,0,0,0,0,0
veno-occlusive disease,1,0,0,0,0,0,1,0,0,0,0,0,0,0
catenin,1,0,0,0,0,0,1,0,0,0,0,0,0,0
tubulin,1,0,0,0,0,0,1,0,0,0,0,0,0,0
Rab GTPase,1,0,0,0,0,0,1,0,0,0,0,0,0,0
cell transformation,1,0,0,0,0,0,1,0,0,0,0,0,0,0
progenitor cells,1,0,0,0,0,0,1,0,0,0,0,0,0,0
SOCs,1,0,0,0,0,0,1,0,0,0,0,0,0,0
isoflurane,1,0,0,0,0,0,1,0,0,0,0,0,0,0
zymosan,1,0,0,0,0,0,1,0,0,0,0,0,0,0
NMDA receptor,1,0,0,0,0,0,1,0,0,0,0,0,0,0
Immunology and Microbiology Section,1,0,0,0,0,0,1,0,0,0,0,0,0,0
Immunity,1,0,0,0,0,0,1,0,0,0,0,0,0,0
HuR,1,0,0,0,0,0,1,0,0,0,0,0,0,0
Hepatic growth factor,1,0,0,0,0,0,1,0,0,0,0,0,0,0
vascular repair,1,0,0,0,0,0,1,0,0,0,0,0,0,0
diannexin,1,0,0,0,0,0,1,0,0,0,0,0,0,0
stem/progenitor cell,1,0,0,0,0,0,1,0,0,0,0,0,0,0
bradykinin,1,0,0,0,0,0,1,0,0,0,0,0,0,0
thromboxane,1,0,0,0,0,0,1,0,0,0,0,0,0,0
vasoconstriction,1,0,0,0,0,0,1,0,0,0,0,0,0,0
vasodilation,1,0,0,0,0,0,1,0,0,0,0,0,0,0
priming,1,0,0,0,0,0,1,0,0,0,0,0,0,0
endothelial growth response 2,1,0,0,0,0,0,1,0,0,0,0,0,0,0
miR-150,1,0,0,0,0,0,1,0,0,0,0,0,0,0
Junction protein,1,0,0,0,0,0,1,0,0,0,0,0,0,0
G protein-couple receptors,1,0,0,0,0,0,1,0,0,0,0,0,0,0
Endothelial barrier regulation,1,0,0,0,0,0,1,0,0,0,0,0,0,0
exocytosis,1,0,0,0,0,0,1,0,0,0,0,0,0,0
secretion,1,0,0,0,0,0,1,0,0,0,0,0,0,0
alpinetin,1,0,0,0,0,0,1,0,0,0,0,0,0,0
TRPC,1,0,0,0,0,0,1,0,0,0,0,0,0,0
Aortic dissection,1,0,0,0,0,0,1,0,0,0,0,0,0,0
skeletal rearrangement,1,0,0,0,0,0,1,0,0,0,0,0,0,0
Vessel permeability,1,0,0,0,0,0,1,0,0,0,0,0,0,0
Beclin-1,1,0,0,0,0,0,1,0,0,0,0,0,0,0
MiR-142a-5p,1,0,0,0,0,0,1,0,0,0,0,0,0,0
compartmentalized cAMP,1,0,0,0,0,1,0,0,0,0,0,0,0,0
bicarbonate,1,0,0,0,0,1,0,0,0,0,0,0,0,0
platelet-endothelial cell adhesion molecule,1,0,0,0,0,1,0,0,0,0,0,0,0,0
KRIT1,1,0,0,0,0,1,0,0,0,0,0,0,0,0
Sp1,1,0,0,0,0,1,0,0,0,0,0,0,0,0
promoter,1,0,0,0,0,1,0,0,0,0,0,0,0,0
HSPA12B,1,0,0,0,0,1,0,0,0,0,0,0,0,0
endothelial wound healing,1,0,0,0,0,1,0,0,0,0,0,0,0,0
wound healing assay,1,0,0,0,0,1,0,0,0,0,0,0,0,0
vascular regeneration,1,0,0,0,0,1,0,0,0,0,0,0,0,0
endothelial repair,1,0,0,0,0,1,0,0,0,0,0,0,0,0
edaravone,1,0,0,0,0,1,0,0,0,0,0,0,0,0
superinfection,1,0,0,0,0,1,0,0,0,0,0,0,0,0
Sox9,1,0,0,0,0,1,0,0,0,0,0,0,0,0
miR-101,1,0,0,0,0,1,0,0,0,0,0,0,0,0
Lung recovery,1,0,0,0,0,1,0,0,0,0,0,0,0,0
pre-B cell colony-enhancing factor,1,0,0,0,0,1,0,0,0,0,0,0,0,0
heat shock protein 27,1,0,0,0,0,1,0,0,0,0,0,0,0,0
Organ injury,1,0,0,0,0,1,0,0,0,0,0,0,0,0
red blood cells,1,0,0,0,0,1,0,0,0,0,0,0,0,0
serine proteases,1,0,0,0,0,1,0,0,0,0,0,0,0,0
PECAM-1,1,0,0,0,0,1,0,0,0,0,0,0,0,0
C3G,1,0,0,0,0,1,0,0,0,0,0,0,0,0
calcitonin gene-related peptide,1,0,0,0,0,1,0,0,0,0,0,0,0,0
cholin transporter-like protein 2,1,0,0,0,0,1,0,0,0,0,0,0,0,0
SH2 domain-containing protein tyrosine phosphatase 2,1,0,0,0,0,1,0,0,0,0,0,0,0,0
pediatrics,1,0,0,0,0,1,0,0,0,0,0,0,0,0
pathobiology,1,0,0,0,0,1,0,0,0,0,0,0,0,0
paxillin,1,0,0,0,0,1,0,0,0,0,0,0,0,0
tyrosine kinase,1,0,0,0,0,1,0,0,0,0,0,0,0,0
H2AX,1,0,0,0,0,1,0,0,0,0,0,0,0,0
MIF,1,0,0,0,0,1,0,0,0,0,0,0,0,0
Pulmonary vascular barrier,1,0,0,0,0,1,0,0,0,0,0,0,0,0
FTY720 S-phosphonate,1,0,0,0,0,1,0,0,0,0,0,0,0,0
rapamycin,1,0,0,0,0,1,0,0,0,0,0,0,0,0
C-type natriuretic peptide,1,0,0,0,0,1,0,0,0,0,0,0,0,0
captopril,1,0,0,0,0,1,0,0,0,0,0,0,0,0
endosome,1,0,0,0,0,1,0,0,0,0,0,0,0,0
guanine nucleotide exchange factors,1,0,0,0,0,1,0,0,0,0,0,0,0,0
Adipose stromal cells,1,0,0,0,0,1,0,0,0,0,0,0,0,0
pulmonary arterial hypertension,1,0,0,0,0,1,0,0,0,0,0,0,0,0
pulmonary embolism,1,0,0,0,0,1,0,0,0,0,0,0,0,0
stretch,1,0,0,0,0,1,0,0,0,0,0,0,0,0
Lung imaging,1,0,0,0,0,1,0,0,0,0,0,0,0,0
porous silicon,1,0,0,0,0,1,0,0,0,0,0,0,0,0
Bcl-2,1,0,0,0,0,1,0,0,0,0,0,0,0,0
MiR-4262,1,0,0,0,0,1,0,0,0,0,0,0,0,0
SMAD2,1,0,0,0,0,1,0,0,0,0,0,0,0,0
SMAD7,1,0,0,0,0,1,0,0,0,0,0,0,0,0
inflammatory mediator,1,0,0,0,0,1,0,0,0,0,0,0,0,0
Cordyceps militaris (CM),1,0,0,0,0,1,0,0,0,0,0,0,0,0
miR-1321,1,0,0,0,0,1,0,0,0,0,0,0,0,0
miR-3188,1,0,0,0,0,1,0,0,0,0,0,0,0,0
CXCR2,1,0,0,0,0,1,0,0,0,0,0,0,0,0
Recombinant PSGL-1-Ig fusion protein,1,0,0,0,0,1,0,0,0,0,0,0,0,0
neutrophil migration,1,0,0,0,0,1,0,0,0,0,0,0,0,0
Ginsenoside Rb1,1,0,0,0,1,0,0,0,0,0,0,0,0,0
qing yin tang,1,0,0,0,1,0,0,0,0,0,0,0,0,0
RBC transfusion,1,0,0,0,1,0,0,0,0,0,0,0,0,0
Direct lung injury,1,0,0,0,1,0,0,0,0,0,0,0,0,0
signaling mechanism,1,0,0,0,1,0,0,0,0,0,0,0,0,0
B cell colony-enhancing factor,1,0,0,0,1,0,0,0,0,0,0,0,0,0
erythropoietin,1,0,0,0,1,0,0,0,0,0,0,0,0,0
Atrial natriuretic peptide,1,0,0,0,1,0,0,0,0,0,0,0,0,0
remifentanil,1,0,0,0,1,0,0,0,0,0,0,0,0,0
Non-muscle myosin light chain kinase,1,0,0,0,1,0,0,0,0,0,0,0,0,0
Stress fibers,1,0,0,0,1,0,0,0,0,0,0,0,0,0
Membrane dynamics,1,0,0,0,1,0,0,0,0,0,0,0,0,0
trauma/hemorrhagic shock,1,0,0,0,1,0,0,0,0,0,0,0,0,0
PDE4B,1,0,0,0,1,0,0,0,0,0,0,0,0,0
Vascular barrier dysfunction,1,0,0,0,1,0,0,0,0,0,0,0,0,0
PAR,1,0,0,0,1,0,0,0,0,0,0,0,0,0
ODSH,1,0,0,0,1,0,0,0,0,0,0,0,0,0
FK-866,1,0,0,0,1,0,0,0,0,0,0,0,0,0
Local anesthetics,1,0,0,0,1,0,0,0,0,0,0,0,0,0
Human lung epithelial cell,1,0,0,0,1,0,0,0,0,0,0,0,0,0
Cell proliferation,1,0,0,0,1,0,0,0,0,0,0,0,0,0
CaSR,1,0,0,0,1,0,0,0,0,0,0,0,0,0
Adult stem cells,1,0,0,0,1,0,0,0,0,0,0,0,0,0
Plasmodium,1,0,0,0,1,0,0,0,0,0,0,0,0,0
Transmission electron microscopy,1,0,0,0,1,0,0,0,0,0,0,0,0,0
Murine model,1,0,0,0,1,0,0,0,0,0,0,0,0,0
ex vivo ventilation perfusion,1,0,0,0,1,0,0,0,0,0,0,0,0,0
PKC inhibitor,1,0,0,0,1,0,0,0,0,0,0,0,0,0
Salbutamol,1,0,0,0,1,0,0,0,0,0,0,0,0,0
Elastance,1,0,0,0,1,0,0,0,0,0,0,0,0,0
Edema,1,0,0,0,1,0,0,0,0,0,0,0,0,0
nuclear translocation,1,0,0,0,1,0,0,0,0,0,0,0,0,0
kinases,1,0,0,0,1,0,0,0,0,0,0,0,0,0
cyclase,1,0,0,0,1,0,0,0,0,0,0,0,0,0
tau,1,0,0,0,1,0,0,0,0,0,0,0,0,0
Blood-borne cells,1,0,0,0,1,0,0,0,0,0,0,0,0,0
fusion to endothelium,1,0,0,0,1,0,0,0,0,0,0,0,0,0
immunopositive cell,1,0,0,0,1,0,0,0,0,0,0,0,0,0
Endothelial targeting,1,0,0,0,1,0,0,0,0,0,0,0,0,0
Antioxidant therapy,1,0,0,0,1,0,0,0,0,0,0,0,0,0
Antioxidant enzyme mimetic,1,0,0,0,1,0,0,0,0,0,0,0,0,0
dimethylarginine dimethylaminohydrolase II,1,0,0,0,1,0,0,0,0,0,0,0,0,0
asymmetric dimethylarginine,1,0,0,0,1,0,0,0,0,0,0,0,0,0
nitrative stress,1,0,0,0,1,0,0,0,0,0,0,0,0,0
gene delivery,1,0,0,0,1,0,0,0,0,0,0,0,0,0
oxidant injury,1,0,0,0,1,0,0,0,0,0,0,0,0,0
protein kinase G,1,0,0,0,1,0,0,0,0,0,0,0,0,0
Interleukin-17,1,0,0,0,1,0,0,0,0,0,0,0,0,0
Protein Structure,1,0,0,0,1,0,0,0,0,0,0,0,0,0
Recombinant Protein Expression,1,0,0,0,1,0,0,0,0,0,0,0,0,0
Redox Regulation,1,0,0,0,1,0,0,0,0,0,0,0,0,0
Superoxide Ion,1,0,0,0,1,0,0,0,0,0,0,0,0,0
Enzymology,1,0,0,0,1,0,0,0,0,0,0,0,0,0
PBEF/NAMPT,1,0,0,0,1,0,0,0,0,0,0,0,0,0
P2Y12 inhibitors,1,0,0,0,1,0,0,0,0,0,0,0,0,0
GPIIb/IIIa antagonists,1,0,0,0,1,0,0,0,0,0,0,0,0,0
PMN,1,0,0,0,1,0,0,0,0,0,0,0,0,0
CD163,1,0,0,0,1,0,0,0,0,0,0,0,0,0
immunohistochemistry,1,0,0,0,1,0,0,0,0,0,0,0,0,0
Platelet activating factor,1,0,0,0,1,0,0,0,0,0,0,0,0,0
Apolipoprotein E,1,0,0,0,1,0,0,0,0,0,0,0,0,0
Acid aspiration,1,0,0,0,1,0,0,0,0,0,0,0,0,0
Oxidized low-density lipoprotein,1,0,0,0,1,0,0,0,0,0,0,0,0,0
Gastric acid aspiration,1,0,0,0,1,0,0,0,0,0,0,0,0,0
vagal stimulation,1,0,0,1,0,0,0,0,0,0,0,0,0,0
Src-suppressed C kinase substrate,1,0,0,1,0,0,0,0,0,0,0,0,0,0
E-selectin,1,0,0,1,0,0,0,0,0,0,0,0,0,0
necrosis,1,0,0,1,0,0,0,0,0,0,0,0,0,0
ultrastructure,1,0,0,1,0,0,0,0,0,0,0,0,0,0
preterm neonates,1,0,0,1,0,0,0,0,0,0,0,0,0,0
reactive nitrogen species,1,0,0,1,0,0,0,0,0,0,0,0,0,0
alveolar collapse,1,0,0,1,0,0,0,0,0,0,0,0,0,0
morphometry,1,0,0,1,0,0,0,0,0,0,0,0,0,0
recruitment maneuvers,1,0,0,1,0,0,0,0,0,0,0,0,0,0
respiratory epithelium,1,0,0,1,0,0,0,0,0,0,0,0,0,0
respiratory mechanics,1,0,0,1,0,0,0,0,0,0,0,0,0,0
"3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT)",1,0,0,1,0,0,0,0,0,0,0,0,0,0
epithelium,1,0,0,1,0,0,0,0,0,0,0,0,0,0
alveolar epithelial fluid transport,1,0,0,1,0,0,0,0,0,0,0,0,0,0
oxidative burst,1,0,0,1,0,0,0,0,0,0,0,0,0,0
phosphodiesterase inhibitor,1,0,0,1,0,0,0,0,0,0,0,0,0,0
PTX,1,0,0,1,0,0,0,0,0,0,0,0,0,0
intersectin-1s,1,0,0,1,0,0,0,0,0,0,0,0,0,0
angiopoietin-like protein 4,1,0,0,1,0,0,0,0,0,0,0,0,0,0
VE-PTP,1,0,0,1,0,0,0,0,0,0,0,0,0,0
hypoxic pulmonary vasoconstriction,1,0,0,1,0,0,0,0,0,0,0,0,0,0
pulmonary artery,1,0,0,1,0,0,0,0,0,0,0,0,0,0
sphingolipids,1,0,0,1,0,0,0,0,0,0,0,0,0,0
sphingosine kinase,1,0,0,1,0,0,0,0,0,0,0,0,0,0
phosphodiesterase,1,0,0,1,0,0,0,0,0,0,0,0,0,0
compartmentalization,1,0,0,1,0,0,0,0,0,0,0,0,0,0
adipose tissue-derived stem cell,1,0,0,1,0,0,0,0,0,0,0,0,0,0
alveolar permeability,1,0,0,1,0,0,0,0,0,0,0,0,0,0
C3a,1,0,0,1,0,0,0,0,0,0,0,0,0,0
Cathepsin G,1,0,0,1,0,0,0,0,0,0,0,0,0,0
Immunoassay,1,0,0,1,0,0,0,0,0,0,0,0,0,0
organ protection,1,0,0,1,0,0,0,0,0,0,0,0,0,0
group V soluble phospholipase A(2) inflammation,1,0,0,1,0,0,0,0,0,0,0,0,0,0
Intestinal barrier,1,0,0,1,0,0,0,0,0,0,0,0,0,0
hypertonic saline,1,0,0,1,0,0,0,0,0,0,0,0,0,0
lipid mediator,1,0,0,1,0,0,0,0,0,0,0,0,0,0
immune complex,1,0,0,1,0,0,0,0,0,0,0,0,0,0
natriuretic peptide,1,0,0,1,0,0,0,0,0,0,0,0,0,0
receptors,1,0,0,1,0,0,0,0,0,0,0,0,0,0
PIM,1,0,0,1,0,0,0,0,0,0,0,0,0,0
Acute lung inflammation,1,0,0,1,0,0,0,0,0,0,0,0,0,0
Gadolinium chloride,1,0,0,1,0,0,0,0,0,0,0,0,0,0
Macrophage depletion,1,0,0,1,0,0,0,0,0,0,0,0,0,0
Cell cultures,1,0,0,1,0,0,0,0,0,0,0,0,0,0
Human lung,1,0,0,1,0,0,0,0,0,0,0,0,0,0
Vessel type,1,0,0,1,0,0,0,0,0,0,0,0,0,0
capillary leak,1,0,0,1,0,0,0,0,0,0,0,0,0,0
arginase 1,1,0,0,1,0,0,0,0,0,0,0,0,0,0
Nitrite,1,0,1,0,0,0,0,0,0,0,0,0,0,0
lung resection,1,0,1,0,0,0,0,0,0,0,0,0,0,0
pulmonary capillary vessel,1,0,1,0,0,0,0,0,0,0,0,0,0,0
Vascular reactivity,1,0,1,0,0,0,0,0,0,0,0,0,0,0
Vascular injury,1,0,1,0,0,0,0,0,0,0,0,0,0,0
crosstalk,1,0,1,0,0,0,0,0,0,0,0,0,0,0
programmed cell death,1,0,1,0,0,0,0,0,0,0,0,0,0,0
multiple organ failure,1,0,1,0,0,0,0,0,0,0,0,0,0,0
lipoprotein,1,0,1,0,0,0,0,0,0,0,0,0,0,0
sphingomyelin synthase,1,0,1,0,0,0,0,0,0,0,0,0,0,0
cytoskeletal rearrangement,1,0,1,0,0,0,0,0,0,0,0,0,0,0
cortical actin,1,0,1,0,0,0,0,0,0,0,0,0,0,0
prevention,1,0,1,0,0,0,0,0,0,0,0,0,0,0
leukocyte antibodies,1,0,1,0,0,0,0,0,0,0,0,0,0,0
lysophospholipid,1,0,1,0,0,0,0,0,0,0,0,0,0,0
lysophosphatidylcholine,1,0,1,0,0,0,0,0,0,0,0,0,0,0
G2A receptor,1,0,1,0,0,0,0,0,0,0,0,0,0,0
G-protein coupled receptor,1,0,1,0,0,0,0,0,0,0,0,0,0,0
clathrin-mediated endocytosis,1,0,1,0,0,0,0,0,0,0,0,0,0,0
Cardamonin,1,0,1,0,0,0,0,0,0,0,0,0,0,0
hydrogen peroxide,1,0,1,0,0,0,0,0,0,0,0,0,0,0
nitric oxide synthase 2,1,0,1,0,0,0,0,0,0,0,0,0,0,0
catalase,1,0,1,0,0,0,0,0,0,0,0,0,0,0
flash photolysis,1,0,1,0,0,0,0,0,0,0,0,0,0,0
resealing,1,0,1,0,0,0,0,0,0,0,0,0,0,0
clodronate,1,0,1,0,0,0,0,0,0,0,0,0,0,0
P-selectin,1,0,1,0,0,0,0,0,0,0,0,0,0,0
CD41,1,0,1,0,0,0,0,0,0,0,0,0,0,0
gp91phox-/-,1,0,1,0,0,0,0,0,0,0,0,0,0,0
Adhesion,1,0,1,0,0,0,0,0,0,0,0,0,0,0
pulmonary vascular leak,1,0,1,0,0,0,0,0,0,0,0,0,0,0
febrile-range hyperthermia,1,0,1,0,0,0,0,0,0,0,0,0,0,0
beta-NAD,1,0,1,0,0,0,0,0,0,0,0,0,0,0
sCD40L,1,0,1,0,0,0,0,0,0,0,0,0,0,0
actin,1,0,1,0,0,0,0,0,0,0,0,0,0,0
nitric oxide synthase,1,0,1,0,0,0,0,0,0,0,0,0,0,0
fibrinogen,1,0,1,0,0,0,0,0,0,0,0,0,0,0
neutrophil recruitment,1,0,1,0,0,0,0,0,0,0,0,0,0,0
oedema,1,0,1,0,0,0,0,0,0,0,0,0,0,0
shedding,1,0,1,0,0,0,0,0,0,0,0,0,0,0
PTP1B,1,0,1,0,0,0,0,0,0,0,0,0,0,0
oxidation,1,0,1,0,0,0,0,0,0,0,0,0,0,0
phorbol myristate,1,0,1,0,0,0,0,0,0,0,0,0,0,0
niacinamide,1,0,1,0,0,0,0,0,0,0,0,0,0,0
isolated perfused lungs,1,0,1,0,0,0,0,0,0,0,0,0,0,0
neutrophil-derived mediators,1,0,1,0,0,0,0,0,0,0,0,0,0,0
Iron complexes,1,0,1,0,0,0,0,0,0,0,0,0,0,0
Remodeling,1,0,1,0,0,0,0,0,0,0,0,0,0,0
Redox-stress,1,0,1,0,0,0,0,0,0,0,0,0,0,0
Rosiglitazone,1,0,1,0,0,0,0,0,0,0,0,0,0,0
"adenosine 3 ',5 '-cyclic monophosphate",1,0,1,0,0,0,0,0,0,0,0,0,0,0
prostanoid EP receptor,1,0,1,0,0,0,0,0,0,0,0,0,0,0
microfluidics,1,0,1,0,0,0,0,0,0,0,0,0,0,0
cell mechanics,1,0,1,0,0,0,0,0,0,0,0,0,0,0
cell adhesion,1,0,1,0,0,0,0,0,0,0,0,0,0,0
cell migration,1,0,1,0,0,0,0,0,0,0,0,0,0,0
cell transmigration,1,0,1,0,0,0,0,0,0,0,0,0,0,0
respiratory distress syndrome,1,0,1,0,0,0,0,0,0,0,0,0,0,0
meningitis,1,0,1,0,0,0,0,0,0,0,0,0,0,0
hyperthermia,1,0,1,0,0,0,0,0,0,0,0,0,0,0
CXC chemokines,1,0,1,0,0,0,0,0,0,0,0,0,0,0
cdc42-deficient,1,1,0,0,0,0,0,0,0,0,0,0,0,0
embryonic development,1,1,0,0,0,0,0,0,0,0,0,0,0,0
CpG DNA,1,1,0,0,0,0,0,0,0,0,0,0,0,0
bacterial DNA,1,1,0,0,0,0,0,0,0,0,0,0,0,0
ECIS,1,1,0,0,0,0,0,0,0,0,0,0,0,0
adherence,1,1,0,0,0,0,0,0,0,0,0,0,0,0
qPCR,1,1,0,0,0,0,0,0,0,0,0,0,0,0
focal adhesion complexes,1,1,0,0,0,0,0,0,0,0,0,0,0,0
margination,1,1,0,0,0,0,0,0,0,0,0,0,0,0
Alveolar type II epithelial cell,1,1,0,0,0,0,0,0,0,0,0,0,0,0
Peroxisome proliferator-activated receptor gamma,1,1,0,0,0,0,0,0,0,0,0,0,0,0
Hedgehog signal pathway,1,1,0,0,0,0,0,0,0,0,0,0,0,0
Sonic hedgehog,1,1,0,0,0,0,0,0,0,0,0,0,0,0
transendothelial resistance,1,1,0,0,0,0,0,0,0,0,0,0,0,0
human toxicology,1,1,0,0,0,0,0,0,0,0,0,0,0,0
alternative methods,1,1,0,0,0,0,0,0,0,0,0,0,0,0
pathology,1,1,0,0,0,0,0,0,0,0,0,0,0,0
junctional complexes,1,1,0,0,0,0,0,0,0,0,0,0,0,0
Mitochondrial DNA,1,1,0,0,0,0,0,0,0,0,0,0,0,0
Oxidative damage,1,1,0,0,0,0,0,0,0,0,0,0,0,0
Ogg1 depletion,1,1,0,0,0,0,0,0,0,0,0,0,0,0
DNA repair,1,1,0,0,0,0,0,0,0,0,0,0,0,0
Free radicals,1,1,0,0,0,0,0,0,0,0,0,0,0,0
hyperinflation,1,1,0,0,0,0,0,0,0,0,0,0,0,0
perivascular edema,1,1,0,0,0,0,0,0,0,0,0,0,0,0
carboxyl stress,1,1,0,0,0,0,0,0,0,0,0,0,0,0
S-nitrosoalbumin,1,1,0,0,0,0,0,0,0,0,0,0,0,0
reduced albumin,1,1,0,0,0,0,0,0,0,0,0,0,0,0
pulmonary smooth muscle,1,1,0,0,0,0,0,0,0,0,0,0,0,0
tert-butyl hydroperoxide,1,1,0,0,0,0,0,0,0,0,0,0,0,0
Lipids,1,1,0,0,0,0,0,0,0,0,0,0,0,0
LTB4 receptors,1,1,0,0,0,0,0,0,0,0,0,0,0,0
BLT1,1,1,0,0,0,0,0,0,0,0,0,0,0,0
BLT2,1,1,0,0,0,0,0,0,0,0,0,0,0,0
Hsp27,1,1,0,0,0,0,0,0,0,0,0,0,0,0
silencing,1,1,0,0,0,0,0,0,0,0,0,0,0,0
Pneumocytes,1,1,0,0,0,0,0,0,0,0,0,0,0,0
Hyaline membranes,1,1,0,0,0,0,0,0,0,0,0,0,0,0
